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ABSTRACT 
I. It was not possible to produce anti-tetracycline antibody in 
laboratory animals by any of the methods tried. Tetracycline 
protein conjugates were prepared and characterized. It was shown 
that previous reports of the detection of anti-tetracycline antibody 
by in vitro ·methods were in error. Tetracycline precipita tes . 
non-specifically with serum proteins. The anaphylactic reaction 
reported was the result of misinterpretation, since the observations 
were inconsistent with the known. mechanism of anaphylaxis and 
the supposed antibody would not sensitize guinea pig skin. The 
hemagglutination reaction was not reproducible and was extremely 
. . . 
sensitive to minute amounts of microbial contamination. Both 
free tetracyclines and the conjugate s were found to be poor 
antigens. 
II. Anti-aspiryl antibodies were produced in rabbits using 3 
protein carrie rs. The m ethod of inhibition of precipitation was used 
to determine the specificity of the antibody produced. ~-Aminocapr-
oate was found to be the most effective inhibitor of the hapte ns tested, 
indicating that the combining hapten of the protein is ~aspiryl-lysylK 
Free aspirin and salicylate s were poor inhibitors and did not combine 
with the antibody to a s ignificant exte nt. The ortho group was found 
to participa te in the binding to antibody. The average binding 
v 
constants were measured. 
Normal rabbit serum was acetylated by aspirin under in vitro 
conditions, which are similar to physiological conditions. The extent 
of acetylation was determined by immunochemical tests. The 
acetylated serum proteins were shown to be potent antigens in rabbits. 
It was also shown that aspiryl proteins were partially acetylated. The 
relation of these results to human aspirin intolerance is discussed. 
III. Aspirin did not induce contact sensitivity in guinea pigs when 
they were immunized by techniques that induce sensitivity with other 
reactive compounds. The acetylation mechanism is not relevant to 
this type of hypersensitivity. since sensitivity is not produced by potent 
acetylating agents like acetyl chloride and acetic anhydride. Aspiryl 
chloride, a totally artificial system, is a good sensitizer. Its 
specificity was examined. 
IV. Protein conjugates were prepared with p-aminosalicylic acid 
and various carriers using azo, carbodiimide and mixed anhydride 
coupling. These antigens were injected into rabbits and guinea pigs 
and no anti-hapten lgG or IgM response was obtained. Delayed 
hypersensitivity was produced in guinea pigs by immunization with 
the conjugates, and its specificity was determined. Guinea pigs were 
not sensitized by either injections or topical application of p-amino-
salicylic acid or p - aminosalicylate. 
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Chapter 1 
IMMUNOCHEMICAL INVESTIGATIONS OF TETRACYCLINES 
Introduction 
The tetracyclines are one of the most important 
classes of broad spectrum antibiotics. Chlortetracycline 
(Aureomycin) was first isolated in 1947 from a mold, 
Streptomyces. Within a few years a large series of tetra-
cycline compounds had been isolated from related molds 
and prepared by chemical modification of the natural 
compounds. In 1952 the structure of oxytetracycline 
(Terramycin) was determined (1,2), and in 1962 the structure 
was confirmed by synthesis (3,4). The structure of tetra-
cycline and the ring numbering system are given in figure 1. 
The rather complex chemistry of the tetracyclines has 
been reviewed recently (5). 
Figure 1 
Tetracycline 
OH 0 
N 
I \ 
CffiCffi 
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In the last fifteen years tetracyclines have come into 
widespread use as antibacterial drugs (6). The only 
antibiotics used more frequently are the penicillins. 
Usually tetracyclines cause only minor side ~ffectsI such 
as staining teeth and disturbing the digestive tract flora, 
causing gastrointestinal distress, nausea, etc. However, 
allergies to most of the commonly used tetracycline 
antibiotics have been reported. Only a few selected 
examples are given in the references. The earliest allergic 
reactions found were to Aureomycin (7,8,9). A short time 
after their introduction, allergy was also reported to 
tetracycline (10,11) and demethylchlortetracycline 
(Declomycin) (12,13). There are collections of case 
histories in several reviews (14,15) and an editorial 
warning about tetracycline allergy has appeared in The 
Journal of the American Medical Association (16). 
Fellner and Baer (11) demonstrated that a reaction to 
tetracycline was the result of allergy by the use of 
direct skin tests, passive hemagglutination and the passive 
transfer (P-K) reaction. Shelly obtained a positive 
reaction using an indirect basophil test (17). Many 
individuals who developed tetracycline allergy were shown 
to be allergic to penicillin also, but clinical data 
indicate that the reactions are independent, and not due to 
a cross reaction or impurities. A photoreaction to 
demethylchlortetracycline has been investigated (18,19,20). 
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This reaction may or may not be caused by an immune 
mechanism. A similar reaction has also been observed with 
6-deoxytetracycline (Doxycycline), but not with tetracycline. 
The high incidence of this reaction in patients who have had 
excessive solar exposure soon after taking the drug 
indicates that the reaction is probably phototoxic (20). 
There have been several attempts to demonstrate anti-
tetracycline antibodies either in vitro or in laboratory 
animals. In 1958 Muelling, Beven, Samson, Jenevein and 
Guillory (21) claimed to have found precipitating antibody 
against tetracycline in the sera of sensitive patients by 
using precipitation tests with free antibiotic as test 
antigen. In 1960 Spektorova (22) immunized rats with 
tetracycline and reported finding precipitation lines in 
gel diffusion tests with free tetracycline from 11 to 45 
days after immunization. The most complete study to date 
was done by Queng, Dukes and McGovern (23). They immunized 
rabbits with free tetracyclines and used both the passive 
hemagglutination and anaphylactic methods to detect 
antibodies. The results and interpretations in each of 
these investigations in some way contradicted the general 
principles of immunochemistry. In the first two studies 
(21,22) a concentration of lmg/ml of free tetracycline was 
used in the precipitation tests. It is very rare when a 
small sized, monovalent hapten can participate in immune 
precipitate formation. It has been clearly established 
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that precipitating antigens must be at least divalent (24). 
Tetracyclines are adsorbed to serum proteins (25) non-
covalently, but this is an equilibrium with substantial 
amounts of free antibiotic in solution. This free 
antibiotic in solution should inhibit precipitate formation. 
Queng ~ al. (23) reported positive passive hemagglutination 
tests, Schultz-Dale reactions with guinea pig gut and a 
"reversed Schultz-Dale" reaction; however, they were 
unable to obtain positive passive cutaneous anaphylaxis 
(PCA) reactions in guinea pigs. It has been established 
that the PCA and Schultz-Dale techniques measure the same 
antibodies and that PCA is at least as sensitive (26). 
Unlike the relatively rare tetracyline allergy, 
penicillin allergy has been extensively studied (27). 
Penicillin and several of its degradation products react 
in vivo with proteins to form immunogenic conjugates. The 
major determinant is the penicilloyl group, but in some 
cases the penicillenate group, other degradation products 
and impurities cause the allergy. A highly conjugated 
protein impurity has recently been found in many conunercial 
preparations. Antibodies to these various determinants 
have been found in the IgE, IgG and IgM classes of inunune 
globulins. IgE is responsible for the cases which exhibit 
urticarial reactions, and IgG and lgM have been detected in 
allergic sera by passive hemagglutination. Penicillin 
allergy has been estimated to occur in about 5% of the 
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American population and is the most common drug allergy 
known. Although at the early stages of investigation 
penicillin allergy seemed to exhibit anomalous irnmuno-
chemical behavior, careful investigation showed that 
penicillin behaved as a collection of classical hapten 
systems when its chemistry was taken into account. 
Because of the apparently anomalous behavior reported 
for tetracyclines, a two-fold investigation was undertaken. 
The first part involved the preparation of .covalently 
bonded protein conjugates of tetracyclines and the study of 
the immunogenicity of these conjugates. The second part 
involved immunochemical and immunological studies of some 
of the previously reported investigations in order to 
clear up the inconsistencies mentioned above. 
Results and Discussion 
A. Conjugates 
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1. Bisdiazotized Benzidine Conjugates 
In 1964 Decarvalho, Rand and Lewis (28) coupled 
tetracycline and other drugs to garrnna globulin using bis-
diazotized benzidine. They did not report either 
experimental data or spectra for the tetracycline 
experiment. Their method was tried but it led to an 
intractable product. The method of coupling described in 
the materials and methods section of this chapter was then 
developed. Conjugates were prepared with tetracycline, 
demethylchlortetracycline, chlortetracycline and oxytetra-
cycline (see figure 2 for structures), using bovine serum 
albumin (BSA), rabbit serum albumin (RSA), giant keyhole 
limpet hemocyanin (KLH). and bovine gannna globulin (BGG) as 
protein carriers. The conjugates were all brown or reddish 
brown in color and had broad absorption bands in the visible 
and ultraviolet. The spectral data for demethylchlortetra-
cycline are given in table 1 and plotted in figure 3. The 
Table 1. Spectral Data for Demethylchlortetracycline 
Substance 
Demethylchlortetracycline (DMC) 
DiazobenzidineazoDMC 
Bisdiazobenzidine 
DMCazobenzidineazoBSA 
Color 
yellow 
red 
green 
Absorp. max. (nm) 
365,275,248,229 
487,282,325-400 
313 
red brown 492,282 
0 
7 
Figure : . 
Structures ot Tetracyclines 
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Figure 3 
Spectra of Demethylchlortetracycline Derivatives 
Demethylchlortetracycline 
xxxxx Demethylchlortetracyclineazodiazobenzidine 
I I I I I DemethylchlortetracyclineazobenzidineazoBSA 
The concentrations are not equalized. 
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spectra of the other compounds are similar. 
The spectral evidence indicates that the tetracyclines 
are not still intact in the conjugates, since most of the 
characteristic spectral features have disappeared. If the 
coupling proceeded without destruction of the tetracycline 
nucleus, the azo group would attach primarily at position 
9 in the 7-chloro compounds and both positions 7 and 9 in 
the 7-unsubstituted compounds. The major directing effect 
on the electrophilic substitution is the o,p effect of 
the phenolic hydroxyl. This greatly outweighs the other 
directing effects. 
Tetracycline, chlortetracycline and oxytetracycline 
are all subject to degradation by bases (29). The 6-de-
methyl compounds are much more resi9tant to this degradation. 
The formation of iso-chlortetracycline from chlortetra-
cycline is shown in figure4. The iso-tetracyclines then 
degrade further. The half life of tetracycline in pH 8.85 
Figure 4 
Base Catalyzed Degradation of Chlortetracycline ( 29) 
/'"OH 
M _,, H Cl .:. 0 N ..  ' Mc2 Mc NMc2 Cl ; H ; 
IOH ~f: . OH ---=- .o If I 
' ""'- : CONH2 -.:-- . l : CONH2 
o) HO 01-1 0 HO (o H O) OHO 
Mc ~McO / ~~~l<eI  
0 0 0 
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buffer is about 12 hours (30). 
also favor epimerization at C-4. 
Slightly basic conditions 
It is probable that much 
of the tetracycline in these antigen preparations is 
degraded. The conjugates are insolubilized by acidification 
or lyophilization, but remain soluble at pH 8.4 to 9.0. 
Storage under these basic conditions, however, favors 
further degradation. After extensive dialysis and storage 
for several months, very little color is removed by further 
dialysis. Under the same conditions other azoproteins 
release considerable amounts of colored hapten. 
2. 7- and 9-Azotetracycline Conjugates 
Small amounts of 7- and 9-amino-6-demethyl-6-deoxy-
tetracyclines were obtained from Dr. J. H. Boothe of 
Lederle Laboratories. Both of these compounds can be 
easily diazotized, and the diazonium salts isolated and 
coupled directly to proteins. 6-Demethyl-6-deoxytetra-
cyclines are also resistant to both acid and base catalyzed 
degradation (31). Spectral data for the 7- series of 
compounds are given in table 2 and figure 5. 
These data indicate that the tetracycline is not 
degraded, since the chromophore is not destroyed. The 
conjugates do not have the deep red or brown color of the 
benzidine conjugates, but are either red or greenish. After 
extensive dialysis and prolonged storage, a material with a 
tetracycline-like spectrum is recovered by further dialysis. 
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Figure 5 
Spectra of 7-Tetracycline Derivatives 
7-Amino-6-dernethyl-6-deoxytetracycline 
I I I I I 7-azo-6-dernethyl-6-deoxytetracyclineKLH 
The concentrations are not equalized. 
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Table 2 
Spectral Data for 7-Amino-6-demethyl-6-deoxytetracycline 
(7-AminoDDT) 
Substance Absorption Maxima {nm2 
7-AminoDDT 345, 274, 250, 200 
7-DiazoDDT 345, 310, 255 
7-AzoDDTKLH 346, 279 
7-AzoDDTRSA 345, 272 
7-AzoDDTBSA 346, 273 
3. In Vivo Conjugates 
Several studies have shown that tetracycline binds to 
serum proteins in vivo. Tetracycline is detectable in 
tissue and protein complexes by fluorescence microscopy. 
When sera from tetracycline treated individuals are 
separated by electrophoresis, the albumin region is 
labelled (25). There is no evidence for covalent bonding. 
The binding is probably ionic or adsorptive. Although much 
tetracycline is excreted in the urine unchanged (32), 
significant amounts are bound in various tissues (33). 
Table 3 gives the amounts of various tetracyclines that 
bind to mouse serum proteins under standard conditions, 
measured in vitro. 
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Table 3 
Binding of Tetracyclines to Mouse Serum Proteins (34) 
Drug % Binding + standard error 
-
6-Deoxyoxytetracycline 69.6 2.6 
6-Methyleneoxytetracycline 69.7 2.1 
6-Demethylchlortetracycline 73.3 1.9 
Tetracycline 54.8 2.2 
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B. Inununization 
1. With Tetracycline-Protein Conjugates 
Various immunization schedules and methods were tried. 
Intravenous injection, Freund's complete adjuvant intra-
muscularly and intradermally, and alumina adjuvant intra-
muscularly were all used. The species used were rabbits, 
guinea pigs and chickens. No animals produced significant 
amounts of antibody against tetracycline, although a few 
produced antibody against azo modified protein. All sera 
were tested by ring tests and passive cutaneous anaphylaxis 
(PCA) in guinea pigs. Precipitation tests with chicken 
sera were done in both 0.9% and 9% saline. 
In order to further investigate the absence of antibody 
production against these haptens, a series of azophenol 
antigens were prepared and tested in rabbits. The phenols 
were selected because tetracycline is attached to protein 
carriers through the phenol ring. Results with these 
antigens were generally negative, as can be seen in table 4. 
This finding was at first attributed to the use of Freund's 
adjuvant (35), but later studies using intravenous 
immunization and glutaraldehyde crosslinked antigens (36) 
also gave negative results with most azoproteins, when 
rabbits of California origin were used. Recently some 
rabbits obtained from Illinois responded to several azo-
proteins. A complete investigation of this problem has not 
been possible; the cause could be either genetic or 
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16 
environmental. It is not due to the antigen preparation. 
Antigens that had previously failed to produce an anti-
hapten response have recently stimulated anti-azohapten 
antibody production in rabbits of midwestern origin. All 
of the animals immunized produced large amounts of antibody 
against the protein carrier. 
Table 5 lists the animals, schedules and procedures 
used with the azobenzidine conjugates, and table 6 the 
data for the azotetracycline conjugates. 
Abbreviations for tables 5 and 6 
Tet -- tetracycline 
Terra -- oxytetracycline 
DMCT -- demethylchlortetracyline 
7-Tet 7-azo-6-demethyl-6-deoxytetracycline 
9-Tet 9-azo-6-demethyl-6-deoxytetracycline 
benz -- azobenzidineazo 
F Freund's complete adjuvant emulsion 
A alumina adjuvant 
iv intravenous 
im intramuscular 
sc subcutaneous 
B -- bleed 
da -- day wk -- week mo -- month 
All unspecified times are 7 days. 
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2. With Free Tetracyclines 
These investigations were undertaken to verify the 
results of Spektorova (22) and Queng, Dukes and McGovern 
(23). lOmg of antibiotic was dissolved in 0.Sml of 
water containing enough NaHC03 to dissolve the drug>and 
this solution was emulsified with 0.6ml of Freund's 
complete adjuvant and injected intraderrnally into 2 sites 
in each rabbit. This procedure was repeated 4 more times 
on alternate days. After resting 2 weeks each rabbit 
received on alternate days 3 intramuscular injections of 
lOmg of antibiotic in buffered saline pH 7.4. After 3 
weeks' rest the first course of injections was repeated and 
the animals then rested for 5 weeks. Finally1 5 daily 
subcutaneous injections of Smg each were administered. The 
rabbits were bled 7 days after the last injection in each 
series. 
None of the sera obtained from these animals contained 
specific precipitating antibody. The results of hemagglut-
ination and anaphylaxis experiments are discussed in later 
sections of this chapter. · The antibiotics used in these 
experiments were tetracycline, demethylchlortetracycline, 
chlortetracycline, oxytetracycline, oxytetracycline hydro-
chloride and an old sample of oxytetracycline, which was 
light brown rather than yellow . 
A group of rabbits was also immunized by painting a 
solution of tetracycline on a shaved area of their backs 
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twice a week for 4 weeks. They showed no skin reaction and 
their sera tested negative by precipitation tests and PCA. 
C. Precipitation Tests 
1. Precipitation with Free Tetracycline 
Two groups of investigators have reported the existence 
of antibody which precipitates with free tetracycline. 
Muelling et al. (21) reported this effect with human 
allergic sera and Spektorova (22) with irmnunized rat sera. 
Both groups used fairly high concentrations of antibiotic 
in their assays, about lOmg/ml, so their results are very 
questionable. In general> specific immune precipitation 
requires antigen which is at least divalent (24). Even if 
one postulates that the tetracycline reacts with or binds 
to the serum proteins of the test serum, one would still 
expect the high free hapten concentration to inhibit 
specific immune precipitation. 
Spektorova's experiments with rats were repeated. Out 
of p rat sera tested>S showed precipitation lines in 
immunodiffusion. After incubating further for 72 hours the 
lines disappeared. 100 anti- and normal sera from rats, 
rabbits and guinea pigs were tested in immunodiffusion 
under the same conditions using lOmg/ml of tetracycline. 
90% showed lines at 24 or 48 hours and in most cases the 
lines disappeared after further incubation. The percentage 
of positive reactions was almost identical in sera from 
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tetracycline treated and non-treated animals. 
Four rabbits were irrnnunized using a schedule similar to 
that used for the rats, and their sera were tested by the 
quantitative precipitation method with final dilutions of 
tetracycline from 5mg/ml to O.lmg/ml. The data for rabbit 
941 are given in figure 6. The amount of precipitate 
increased with increasing amounts of tetracycline up to the 
highest concentration used. There was free tetracycline 
left in all of the tubes. Both observations contradict 
the behavior of irrnnune precipitates. In addition there 
was not inhibition by free hapten. Neither of the two 
articles referred to above mentioned control experiments 
with normal sera. The experiments reported here show that 
free tetracycline is able to non-specifically precipitate 
certain serum proteins when added at concentrations of 
1-lOmg/ml. 
2. Immunoadsorbents 
As a part of this study an evaluation was made of 
different methods of specifically purifying antibody. One 
reason was to find the best method for purifying antibody 
against tetracycline, when it was obtained, and another 
was to prepare highly purified antibody for developing and 
evaluating the various techniques used. Specifically 
purified antibody was of great value in developing the 
Schultz-Dale method and the equilibrium dialysis method 
22 
/v, 0 
x 
Sp 
0 
l K ~P 
Figure 6 
Precipitation of Serum 941 (1/5/67) by Free Tetracycline 
Abcissa- Concentration of tetracycline 
Ordinate- Protein in absorbance units 
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used in these studies. The detailed methods for preparing 
and using the immunoadsorbents are given in the materials 
and methods part of this chapter. 
Each adsorbent was prepared and tested with at least 
two antigen-antibody systems. Quantitative tests were 
performed to determine recoveries and purities from 
adsorbents which gave a good yield of pure antibody. The 
polyacrylamide gel method was the best system tried. It 
could be prepared from free proteins and amide coupled and 
azo coupled conjugates in less than 6 hours. It was easy 
to elute, and antibody was recovered in high yield. The 
adsorbent was reusable, but with loss of capacity. One 
special feature of this adsorbent is that the pore size of 
the gel can be enlarged or reduced for different sized 
antigens. It was also an efficient preparationlsince it 
bound almost all of the antigen used in its preparation. 
Free proteins crosslinked by either glutaraldehyde or ethyl 
chloroforrnate were also excellent adsorbents, but many 
conjugates can not be crosslinked linked enough to become 
insoluble by these procedures. Azo and acid chloride 
coupling block the free amino groups necessary for cross-
linking. The various immunoadsorbents tried are compared 
in table 7. 
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D. Passive Hemagglutination 
Queng, Dukes and McGovern (23) tested sera from 
rabbits immunized with tetracycline, chlortetracycline, 
oxytetracycline and demethylchlortetracycline by passive 
hemagglutination and inhibition of passive agglutination. 
Two rabbits immunized with oxytetracycline showed titers of 
640 and 5120 against oxytetracycline. All of the other 
sera tested negative or extremely low against the immunizing 
antigens. The positive sera exhibited little or no cross-
reactivity with other tetracyclines. These results were 
unexpected since the incidence of allergy to oxytetracycline 
is significantly lower than that to any of the other 
compounds they used. The positive sera were chromatographed 
on DEAE-Sephadex and the activity was found after processing 
parts of the first two peaks. The first peak was lgG. 
The positive sera did not give PCA reactions in guinea pigs. 
A group of rabbits was immunized with free 
tetracyclines according to the method of Queng et al. (23) 
and tested both by the tube hemagglutination technique (23) 
and a micro modification of it. It was found that the 
substitution of a buffered gelatin solution for normal 
serum in the final washing of cells and also as diluent 
greatly decreased the problem of non-specific agglutination 
and variation of the sensitivity of the assay. Three 
different samples of oxytetracycline were used; one was 
quite old and probably significantly degraded. The sera 
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from rabbits immunized with tetracycline, chlortetracycline 
and demethylchlortetracycline all tested negative or titered 
less than 20 each time they were tested. Each animal was 
bled before and 4 times during the immunization schedule 
and the sera were tested each time. At various times sera 
from rabbits immunized with oxytetracycline tested positive; 
however the variation in the titers was unsystematic. In 
the course of these experiments it was found that the 
oxytetracycline hemagglutination system was extremely 
sensitive to microbial contamination. The entire 
experiment was then repeated with new rabbits and the sera 
were kept sterile by membrane filtration and storage at 
-20° . . This time all of the sera were negative. 12 rabbits 
were used in this experiment. Since they all tested 
negative, it was not possible to evaluate the inhibition 
system. The micro method, using microtiter plates, was 
much more reproducible than the tube method for all four 
antigens. The cells were prepared by the literature 
method (23), since one could not maximize the sensitivity 
without a positive control serum for each drug. 
E. In Vitro Anaphylaxis 
It has been maintained by Queng et al. (23) that sera 
from rabbits innnunized with oxytetracycline can passively 
sensitize guinea pig ileum in the Schultz -Dale technique. 
The same authors also state that the identical rabbit sera 
27 
could not sensitize guinea pig skin for passive cutaneous 
anaphylaxis. Both reactions are manifestations of 
sensitization by the same classes of antibodies. Rabbit 
IgG is known to sensitize guinea pig tissues, while rabbit 
IgM and IgA do not (37). 
The sequence of events in anaphylactic reactions has 
been extensively studied (38) and more recent research has 
confirmed the proposed mechanism; a simplified version of 
the mechanism as it is presently understood follows. 
The Fe end of certain globulins is able to couple to 
specific receptors on mast cells of various tissues. 
Globulins which can sensitize animals of the same species 
may be different from those that can sensitize other 
species. For example human IgG2 sensitizes guinea pig skin 
but not human or monkey skin, while human IgE sensitizes 
both human and monkey skin. Non-specific globulin competes 
with specific antibody on a concentration basis for the 
available mast cell combining sites. The globulins are 
bound firmly to the tissues and are not removed by extensive 
washing, but can be removed with non-specific globulin. 
The bound antibody can combine with antigen and initiate a 
series of events involving the cell, possibly by a steric 
effect. These events terminate in the release of vaso-
active substances, particularly histamine and serotonin 
from the mast cells. Mast cell histamine is bound to 
heparin in the granules of the mast cells, and degranulation 
28 
is observed during an anaphylactic reaction. Figure 7 is 
a very schematized diagram of these events. 
A second inconsistency in the interpretation of 
Schultz-Dale data by Queng et al. (23) is the claim that 
not only can guinea pig gut be passively sensitized to 
oxytetracycline with irrnnune sera, but also that the gut can 
be passively sensitized with oxytetracycline and then react 
with immune sera. This interpretation is completely 
inconsistent with the mechanism presented above, which is 
based upon a large accumulation of empirical evidence. 
The experiments of Queng et al. (23) were repeated and 
extensively studied to find the cause of this inconsistency. 
Figures 8 and 9 show experiments of Queng, Dukes and 
McGovern (23). Figure 10 shows the reactions of a piece of 
gut sensitized with oxytetracycline, challenged with 
irrnnune globulin, washed again, and challenged with 
oxytetracycline. Figure 11 shows a piece of normal gut 
sensitized with irrnnune serum, washed, challenged with 
tetracycline, washed, and challenged again with irrnnune 
serum. Figure 12 shows the reaction of another piece of 
gut sensitized with anti-DNPBSA globulins and challenged 
with DNPBSA. This is a true Schultz-Dale reaction. 
Desensitization is observed with the anti-DNPBSA sensitized 
gut: The reaction is not visible after the second challenge, 
which is already quite weak. In all of the tetracycline 
and oxytetracycline experiments "desensitization" was 
29 
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Figure 7 
Schematic Diagram of Anaphylaxis 
1. Mast cells and antibodies 
2 . Fixation of antibodies 
3. Combination of antigen with antibody 
4. Release of histamine and serotonin 
a mast cell 
b cell 
c antibody 
d antigen 
h histamine 
s serotonin 
mast cell granules 
·" 
30 
10 
9 
i 8 ~ 
"' z 7 
0 
t- 6 
v 
< .. a< 5 t- .. 
z ~ 
0 c 
v • 
Figure 9 
Schultz-Dale experiments from Queng, Duk es and McGovern (23) 
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r 
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1 2 3 
Figure 10 
Schultz-Dale experiment with normal guinea pig ileum 
1 0.2ml serum A57 passive sensitization 
2 0.02 micrograms histamine 
3 0.4mg oxytetracycline 
Discontinuities indicate time and washes. 
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j 
1 2 3 4 
Figure 11 
Schultz-Dale experiment with oxytetracycline sensitized gut 
1 0.05ml A61 total globulins 
2 0 . 2mg tetracy cline 
3 0.02 microgram histamine 
4 0.05ml A61 total globulins 
Discontinuities are time and washes. 
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1 2 3 
Figure 12 
Schultz-Dale experiment with dinitrophenylBSA sensitized gut 
1 0.02 microgram histamine 
2 O.OSmg dinitrophenylBSA 
3 0.02 microgram histamine 
Discontinuities are time and washes. 
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gradual and several challenges were required for the 
reaction to disappear. Tetracycline and demethylchlor-
tetracycline elicited only weak responses from sensitized 
gut. Queng et al. (23) claimed that O.lmg of drug was non-
irritating, but that amount of oxytetracycline was able to 
cause a contraction. They did not specify whether or not 
they used whole serum for testing. If they did, one would 
expect contractions from the effects of adding serum to 
the Tyrode and from the free histamine and histamine 
releasers in the Tyrode. 
A recent study showed that tetracycline caused major 
reductions in the histamine and serotonin contents of 
mouse intestine (39). This effect could be the result of 
association of the tetracycline with serum proteins on the 
intestinal wall,causing the release of histamine and 
serotonin. This would also explain the results of the 
Schultz-Dale experiments. 
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Conclusions 
It was not possible to produce a significant amount of 
antibody against tetracycline in laboratory animals by any 
of the methods tried. This was not unexpected, since 
tetracycline allergy is quite rare among patients given 
tetracycline therapy. However, it was found that the 
previous reports of the detection of antibody against 
tetracycline by in vitro experiments were in error. 
The precipitation reactions reported in the literature 
were unequivocably shown to be non-specific, due to the 
association of tetracycline with serum proteins. The 
hemagglutination reaction was not reproducible and is 
highly suspect because of the interactions of some 
tetracyclines with proteins at cell surfaces. It was also 
extremely sensitive to microbial contamination. The 
anaphylactic reactions reported were the result of mis-
interpreted data. None of the papers that reported in 
vitro detection of antibody against tetracyclines gave any 
evidence that proper control experiments were performed. 
Tetracycline is a poor immunogen, and human hyper-
sensitivity to it will probably have to be studied in 
allergic individuals and monkeys to elucidate the mechanism. 
Materials and Methods 
A. Materials 
1. Antibiotics 
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The tetracycline antibiotics were all obtained from 
manufacturers and were all samples of batches intended for 
pharmaceutical use. The two aminotetracyclines were a 
gift from Dr. J. H. Boothe of Lederle Laboratories. 
Antibiotic 
Chlortetracycline HCl 
Tetracycline HCl 
Demethylchlortetracycline HCl 
7-Arnino-6-demethyl-6-deoxytetracycline 
9-Arnino-6-demethyl-6-deoxytetracycline 
Oxytetracycline 
Oxytetracycline HCl 
Oxytetracycline (old) 
L* 
L 
L 
HCl L 
HCl L 
p 
p 
p 
* L - Lederle Laboratories, Pearl River, N. Y. 
P - Charles Pfizer and Co., Brooklyn, N. Y. 
48015-893 
48016-1284 
48151-748 
7348B-156-l 
5478B-149-l 
78190-53010 
7Y536-51010 
unknown 
c. 1950 
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2. Freund's Adjuvant 
Freund's adjuvant, complete, was obtained from Difeo, 
Detroit, Michigan. This conunercial product was superior to 
a preparation made with 9 parts of Marcel 52 (Humble Oil 
Co.), 1 part of Arlacel F (Atlas Powder Co.) and killed 
Mycobacteria. The latter antigen was more difficult to 
emulsify than the Difeo product; l.2ml of adjuvant were 
mixed with lml of antigen solution. The pH of antigen 
solutions should be either more than 7.4 or less than 5 to 
form stable emulsions. 
3. Proteins 
Bovine serum albumin (BSA) and bovine ganuna globulin 
(BGG) were obtained from Armour Pharmaceuticals, Kankakee, 
Illinois. Rabbit serum albumin (RSA) was obtained from 
Pentex, Inc., Kankakee, Illinois. 
Giant keyhole limpet hemocyanin (KLH) was prepared by 
a modification of the method of Campbell~ al. (40). 
Fresh giant keyhole limpets, Megathura crenulata, obtained 
the same day from Marineland of the Pacific were slit in 
the foot and placed on ~ inch wire mesh that covered the 
top of enamelled pans in the cold room at 40. When all the 
body fluid had drained into the pan, the carcasses were 
discarded, and the fluid was centrifuged at 3000rpm for 30 
minutes, and the supernatant was then filtered through 
fluted filter paper. The hemocyanin was then sedimented in 
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the 30 head of a Spinco Ultracentrifuge for 90 - 120 
minutes at 30,000rpm. Samples were prepared and stored in 
two different ways. 5ml of saline was added to each of a 
group of tubes that were stored frozen at -20°. 5ml of 
s a turated anunonium sulfate was added to each of a group of 
0 tubes that were stored at 4 • Before the use of any sample 
the liquid was poured from the tube and the pellet was 
dissolved in saline. The solution was centrifuged at 3000 
rpm for 15 minutes; the supernatant was then filtered and 
the hemocyanin resedimented for 90 minutes at 30,000rpm in 
the ultracentrifuge. The pellets were redissolved in 
saline and again centrifuged at 3000rpm for 15 minutes. The 
supernatant was then dialyzed against saline. Recovery of 
hemocyanin from the material stored under annnonium sulfate 
solution was much greater than from frozen material. 
Ammonium sulfate appears to inhibit degradation. The 
concentration of hemocyanin after the above processing was 
generally from 25-40mg/ml. 
4. Borate-saline Buffer 
6.18g of boric acid, 9.54g of Na2B407 ·10H20 and 4.38g 
of sodium chloride were dissolved in one liter of distilled 
water. The pH was between 8.4 and 8.6. 
B. Preparation of Antigens 
1. Benzidine Coupling 
39 
Benzidine coupling was done by a modification of 
Kabat's method (41). 
DemethylchlortetracyclineazobenzidineazoBSA 
64mg of benzidine dihydrochloride was dissolved in 10 
ml of water and 0.3ml of 6N HCl and cooled in ice. 0.85ml 
of sodium nitrite solution containing 35mg was added, and 
the colored solution was stirred for 25 minutes at 2-4°. 
Excess HN02 was destroyed by the addition of small 
quantities of solid sulfamic acid until tests with starch-
iodide paper were negativ·e. The tetra-azotized benzidine 
was poured into 50ml of cold 0.6% sodium acetate and the pH 
was adjusted to 8 with 2N NaOH. 125mg of demethylchlor-
tetracycline hydrochloride was added in pH 8 buffer, and the 
solution was stirred in the cold for 10-15 minutes at pH 8. 
The demethylchlortetracyclineazodiazobenzidine was then 
slowly added to a cold solution of 250mg of BSA in saline, 
while the pH was kept between 8.2 and 8.6. After the 
addition was completed, the solution was allowed to stand 
for 20 hours in the cold, and then it was dialyzed against 
1:20 borate-saline buffer in saline pH 8.4 until there was 
no ultraviolet absorption in the dialysate. The solution 
was then dialyzed against borate-saline buffer, which 
solubilized almost all of the conjugate. Conjugates can 
also be purified on Bio-Gel or Sephadex columns. 
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2. Diazo-6-demethyl-6-deoxytetracyclines (42) 
28 microliters of n-butyl nitrite were added to 25mg 
of 7 or 9-amino-6-demethyl-6-deoxytetracycline hydrochloride 
in 0 0.5ml of O.lM HCl in methanol at 0 . The solution was 
allowed to stand for 30 minutes; then lOml of ether was 
added, the mixture centrifuged and the liquid discarded. 
5ml of cold saline was added, and the remaining ether was 
removed with a capillary pipet. The resulting solution was 
used directly for protein coupling. The ultraviolet 
absorption spectra of both diazo compounds matched those 
reported in the literature. 
3. Protein Conjugation 
The diazotetracycline solution from 2 was added to 
225mg of RSA in 25ml of 0.05M sodium phosphate-0.lM saline, 
pH 7, at 4°. The pH was then a djusted to 7.8 and the 
coupling was allowed to procede overnight in the cold. The 
solution was then dia lyzed against borate-saline buffer pH 
8.4 diluted 1:20 in saline, until there was no absorbance 
in the dialysa t e at 315nm. 
4. Diazophenols 
109mg of meta-aminophenol in lOml of water and 0.4ml 
of 6N HCl was coole d to 2°. l.7ml of cold 4% sodium nitrite 
was added and the solution was stirred for 15 minutes. The 
excess nitrous acid was destroyed with s ulfamic acid until 
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the starch-iodide test was negative. This solution was 
then added to a cold solution of 300mg BSA in 25ml of 
borate-saline pH 8.4. After 18 hours in the cold, the 
solution was extensively dialyzed. The same procedure was 
used with various haptens and carriers. 
5. Alumina Adjuvant (43) 
4ml of water was added to l.6ml of 10% AlKS04 • The 
mixture was brought to pH 7.2 by adding about lml of lN 
NaOH and then diluted to 25ml. It was then centrifuged for 
5 minutes and the supernatant was discarded. The alumina 
was suspended in 4ml of saline, and 0.2ml of Smg/ml 
antigen in O.lM TrisHCl pH7.9 was added. The solution was 
diluted to 9.3g with saline with the pH adjusted to 6.4 
with lN HCl. After standing 30 minutes l.Sml of the 
suspension was injected intramuscularly into each rabbit. 
C. Immunochemical Methods 
1. Ring Test 
Interfacial tests were used for qua litative detection 
of pre cipitating antibody. 3-Snnn of each component was 
layered in a 6x50nnn test tube so that an interface formed. 
If both of the components were dilute solutions, sucrose 
wa s added to one in order to make the interface more 
stable. Tubes were coate d on the outside with mine ral oil 
to r e duce light scattering by s cratches on the glass , so 
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that r e actions could be more clearly observed. All 
observations were made in a shadow box. 
2. Irrununodiffusion 
lg of Noble agar (Difeo) or 0.9g of Ionagar was 
dissolved at 95° in 95ml of 0.9% saline and 5ml of borate-
saline buffer pH 8.4. The hot medium was pipetted into 
35xl0rrun plastic Petri dishes and was allowed to solidify. 
Wells were cut with LKB punches, and the plugs removed 
using a disposable pipet connected to vacuum. 2-3 micro-
liter samples of both antigen and antibody were used. 
Diffusion took 24-48 hours at room temperature or at 37°. 
The plates were then washed for 36-48 hours in saline and 
air dried under filter paper. The dried plates were 
stained with 0.1% amido black in 5% sulfosalicylic acid 
and 5% trichloroacetic acid. The backgrounds were cleared 
with 5% acetic acid. 
3. Irmnunoelectrophoresis 
Inununoelectrophoresis was performed using the Millipore 
Immuno-PhoroSlide system. Strips of either pattern were 
pre-buffered by standing on edge in a slide box containing 
3mm of half strength Millipore barbital buffer (original 
ionic strength 0.075, pH 8.6) until the liquid reached the 
top of the strip. The strip was then blotted and placed 
in the Millipore chamber containing 5.5ml of half strength 
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buffer in each buffer compartment. 0.8 microliter of 
sample was deposited in each well, and the chamber was 
covered. It was then connected to a modified Spinco power 
supply and operated at 100 volts for 18 minutes. The slide 
was then removed and fastened to a glass slide with double 
sided tape. 25-40 microliters of Hyland goat anti-rabbit 
or anti-human serum was placed along each trough, and the 
slide was placed in a water saturated diffusion chamber for 
48 hours. The PhoroSlide was then removed from the glass 
slide and the top plastic layer was peeled off. The 
cellulose acetate strip was then washed in normal saline 
for 2-12 hours at 40°. The slide was then stained in 0.05% 
nigrosin in 5% sulfosalicylic acid, 5% trichloroacetic acid. 
The background was cleared in 5% acetic acid and the slide 
washed in water before drying in air. 
Regular electrophoresis was performed by a similar 
procedure using Millipore PhoroSlides. Full strength 
Millipore buffer was used and samples were applied with 
Millipore applicators. The diffusion and washing steps 
were not necessary and the stain already contains a protein 
fixative. Either amido black, Ponceau S or nigrosin can be 
used for staining electrophoresis slides. 
4. Precipitation Tests 
Equal amounts of antigen and antibody solution (0.25 
or 0.5ml each) were mixed in 13x100mm test tubes. Serial 
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dilutions were made in borate-saline buffer pH 8.4 and 
were either a twofold series or a 1,2,3,4,6,8,10 series. 
Each dilution was prepared in duplicate. The tubes were 
incubated 1-2 hours at 37° followed by 48 hours at 4°. The 
precipitates were resuspended with a vortex mixer at 24 
hours. After the incubation was completed, the tubes were 
centrifuged at 3000rpm for 35 minutes at 4° and the super-
natants were decanted. The equivalence zone was located 
by ring testing the supernatants. Each precipitate was 
washed twice with 5ml of borate- saline by centrifuging at 
3000rpm for 35 minutes at 4°. After decanting, the tubes 
were inverted to drain. Protein was assayed by either the 
Nessler reaction or ultraviolet absorption. Other methods 
of protein determination were usually not applicable to the 
systems being studied. Precipitation curves were plotted, 
and the amount of antibody was calculated from the curve 
by taking the highest value after subtracting the antigen 
added. This value should occur in either the equivalence 
or antibody excess zones. Antibody solutions were 
decomplemented either by adsorption with a preformed 
heterologous precipitate or by the use of serum globulin 
fraction or specifically purified antibody. 
5. Nessler Reaction 
Protein nitrogen was determined by the Nes sle r r e action 
(44). Standards were pre pared tha t contained arrunonium 
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sulfate in the range of 10-200 micrograms of nitrogen. 0.2 
ml of concentrated sulfuric acid was added to each tube: 
sample, standard and blank. The tubes were placed in a 
metal rack and heated over a low flame from a Fisher burner 
for 15-20 minutes until all the water was removed. The 
flame was turned up to digest the samples. The rack was 
periodically rotated to heat the tubes evenly,and the sides 
of the tubes were flamed with another burner to prevent 
condensation. The tubes were digested for 5-10 minutes 
after the sulfuric acid refluxed. The total heating time 
was about 20-25 minutes. The tubes were cooled for 1-2 
minutes and 2 drops of 30% hydrogen peroxide were carefully 
added to each tube. The tubes were then heated over a low 
flame; hydrogen peroxide was added again to all tubes 
which were not colorless. They were heated for 10-15 
minutes until the acid refluxed. The tubes were removed 
from the flame and cooled to room temperature. 7ml of 
water was added to each tube, and then the contents of each 
tube was poured into a separate 19xl50mrn tube. Each 
digestion tube was then rinsed with another 7ml of water, 
which was also transferred to the large tube. A button 
bottom stirring rod was placed in each tube and 6ml of Koch 
and McMeekin formula Nessler reagent (45), freshly filtered 
through a sintered glass funnel, was added, and the 
mixtures stirred. After standing for 30 minutes, the OD 
readings were made at 440nrn. 
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6. Protein Determination by Ultraviolet Absorption 
Free protein or protein in precipitates was determined 
by solution in O.lN NaOH and measuring absorbance at 280nm. 
Either 3 or 5ml of NaOH was used for precipitation tests. 
The method was standardized for each protein by Nessler 
determination. The values are given in table 8. 
Table 8 
Protein Abs. lmg/ml, 280nm, O.lN NaOH 
Keyhole limpet hemocyanin 1.56 
Bovine serum albumin 0.67 
Rabbit serum albumin 0.63 
Rabbit antibody (IgG) 1.50-1.61 
7. Separation of the Serum Globulin Fraction 
0.5 volume of saturated reagent grade ammonium sulfate 
was dropped into 1 volume of serum with stirring at room 
temperature. After stirring for 30 minutes, the suspension 
was centrifuged for 10 minutes at 3000rpm and reconstituted 
to the original volume of serum with saline. The 
precipitation was repeated twice more and the precipitated 
globulins were dissolved in ~ to ~ volume of saline. The 
solution was then dialyzed against 6-8 changes of normal 
saline, buffered at pH 7 to 8.4 and was then centrifuged 
to remove the small amount of insoluble material. These 
preparations were albumin free by immunoelectrophoresis. 
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8. Ultrafiltration 
Purified protein solutions were concentrated by ultra-
filtration. The membrane that gave the best results was an 
Amicon Corporation (Cambridge, Mass.) UM20E, which passed 
molecules smaller than molecular weight 20,000. 50 psi of 
prepurified nitrogen was used to force the liquid through 
the membrane in the 65ml cell. Other membranes were much 
slower or did not retain all of the antibody. 
9. Animals and the Preparation of Sera 
Rabbits were obtained from Adams Caviary, Horton's 
Laboratory Animals, and California Caviary; all were 
New Zealand albino males. No animals were used that weighed 
less than 5lbs. Bleeding was from the ear vein using a 
vacuum bleeder, except when the animals were sacrificed by 
cardiac exsanguination. The blood was allowed to clot at 
room temperature for 3 hours and then was centrifuged 
twice for 15 minutes at 1700rpm. The sera were clarified 
by ultracentrifugation at 30,000rpm for 45 minutes, which 
made the lipids float so that they could be easily removed. 
Any solids present were removed by pressure filtration 
through an 0.45 micron membrane filter. When possible, 
sera were stored frozen, otherwise they were kept at 4°. 
Preservatives were not used. 
Guinea pigs were all from the Caltech colony. They are 
an albino, American type called Campbell-Trapani strain. 
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The animals have been randomly bred in a completely closed 
colony. The strain is distinguished by large ears and very 
constant immune reactivity; passive cutaneous anaphylaxis 
reactivity differs among various individuals by less than a 
factor of 5 (46). The animals were bled by heart puncture, 
and the serum was processed the same way as rabbit serum. 
Rats were obtained from various sources and were bled 
by heart puncture. 
Chickens were bantams of both sexes, obtained locally. 
They were injected in the wing vein or intramuscularly in 
the leg. Bleeding was usually done by cardiac puncture. 
Sera were processed in the usual manner. 
All animals were fed proper laboratory diets. Guinea 
pigs received either fresh kale or carrots and vitamin C in 
their water in addition to pellets. At various times guinea 
pigs and rabbits received either sulfa or peptide 
antibiotics in their feed to control infections. At one 
time there was a pneumonia outbreak in the guinea pig 
colony. Snuffles (Pasteurella leptiseptica) was usually 
present in the rabbit colony and caused the loss of many 
experimental animals. No animals received either 
tetracycline or penicillin antibiotics as either therapeutic 
or control measures. The only exposure to tetracyclines 
was the immunization. 
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10. Passive Cutaneous Anaphylaxis (26) 
250-500g guinea pigs were sensitized by injecting 0.1 
ml of varying dilutions of antisera intradermally using a 
26 or 27 gauge intradermal bevel needle into an area of 
their backs shave d with a number 000 electric clipper. 
Sensitization times were 3-4 hours for rabbit antibody and 
either 3-4 or 18 hours for guinea pig antibody. Passive 
Arthus reactions were challenged innnediately after intra-
dermal injection with a 30 gauge needle. The guinea pigs 
were challenged by intracardiac injection of 0.5ml of 
antigen in saline mixed with 0.5ml of 1% Evans blue in 
saline. Reactions were observed and measured at 15, 30 
and 120 minutes after challenge. The guinea pigs were then 
sacrificed and skinned. The skins were stretched and 
covered with Boraxo to dry. The diameters of the reactions 
were then measured on the reverse side of the skin. Saline 
controls were performed on each animal, and normal serum 
and carrier controls were always done to verify positive 
anti-hapten reactions. 
11. Passive Hemagglutination (23,47,48) 
Sheep blood was obtained from Davis Laboratories, 
Davis,California, and was always from the same animal. Red 
cells were always centrifuged at 1000-1500rpm for 7-10 
minutes. The red cells were washed 3 times with 0.9% saline 
and suspended to a concentration of 2.5% (v/v) in 1:1 
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saline-0.7M sodium phosphate buffer pH 7.2. An equal 
volume of freshly diluted 1:20,000 tannic acid in phosphate 
buffered saline pH 7.2 was added, and the cells were 
incubated at 37° for 10 minutes. They were then washed with 
phosphate buffered saline pH 7.2 and with saline. The cells 
were suspended in phosphate buffered saline pH 6.4 to a 
concentration of 2.5% and a solution of tetracycline in 
phosphate buffered saline was added to give a final 
concentration of 2.5mg of drug per milliliter of packed 
cells. After incubation at 37° for 30 minutes, the cells 
were washed with saline and then twice with freshly prepared 
0.2% Difeo Bacto gelatin in O.llM phosphate pH 7.3. The 
cells were resuspended in gelatin phosphate to a final 
concentration of 0.5%. Complement was inactivated by 
heating the sera at 60° for 30 minutes, and the sera were 
adsorbed with 50% tanned red cells to remove non-specific 
agglutinating substances. The adsorbing cells were prepared 
by the above procedure leaving out the tetracycline. 
Dilutions were made using gelatin phosphate as the diluent. 
The tests were carried out with 0.025ml volumes using a 
Cooke Engineering Microtiter set. The titer was expressed 
as the reciprocal of the highest dilution which agglutinated 
the cells, when read at 12-18 hours. A tube method that 
gave similar results was used earlier, but it was 
experimentally more difficult and required much more 
material. 
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12. In Vitro Anaphylaxis (49) 
Tyrode Solution 
8.000g 
0.195g 
0.146g 
0.213g 
l.OOOg 
l.OOOg 
Sodium Chloride, Biological Grade 
Potassium Chloride 
Calcium Chloride, Anhydrous 
Magnesium Chloride·6H20 
Sodium Bicarbonate 
Glucose, recrystallized from ethanol-H20 
The above chemicals were dissolved in order in 1 
liter of glass distilled water. The solution was then 
saturated with o 2 , not 02-co2 as is given in the reference. 
The final pH was adjusted to 7.8 at 37°. Lower pH inhibits 
the reaction. The solution was prepared fresh each day. 
Isotonic Buffered Glucose 
55.lg of recrystallized glucose and 43mg of sodium 
bicarbonate were dissolved in 1 liter of glass distilled 
water. The final pH was 7.3. Isotonic buffered glucose 
was sometimes used for passive sensitization. 
Guinea Pig Gut 
Guinea pigs were sacrificed by exsanguination or by a 
blow to the base of the skull. The abdomen was opened and 
lOml of warm Tyrode solution was poured in to the cavity. 
The small intestine was cut 7-lOcm from the cecum (junction 
with the large intestine). The gut was extended and it was 
pulled free from the mesentery. 20-30cm was removed and 
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the remaining mesentery and fat was trirruned off. The 
intestine was washed by allowing Tyrode solution to flow 
through it from a lOml volumetric pipet by gravity. The 
intestinal contents were completely removed by 2 rinses. 
The gut was then placed into fresh Tyrode solution and 
refrigerated for 2-3 hours; this decreased spontaneous 
contractions. l.5-2cm pieces were used for experiments. 
A length of silk thread with a pretied loop was tied through 
each end of the gut using a curved suture needle. The ends 
of the gut should not be tied off, if they are, gas collects 
in the lumen. Each piece of gut was always equilibrated for 
at least 20 minutes before being tested. Uterus horns were 
tried in several experiments, but the background 
contractions were much stronger than those from gut. Gut 
was used on the same day it was obtained. Samples stored 
at 4° overnight were significantly less sensitive and 
required much longer equilibration times, 2 to 3 times 
those of fresh gut. 
Apparatus 
Contractions were recorded on either a Grass Instrument 
(Quincy, Mass. ) model SA polygraph using an FT.03c strain 
gauge (50g/rrun) or a Harvard Apparatus Co. (Millis, Mass.) 
model 356 transducer and model 350 recording module. The 
Grass Instruments apparatus measures the contractions 
isometrically, since the distance the strain gauge arm 
moves is less than 0.02rrun. The Harvard apparatus measures 
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the contraction isotonically; the load was set at 2g. The 
kymograph speed for the Harvard apparatus was 2.06cm/minute. 
The vessel is diagrammed in figure 13. The inside of 
Figure 13 
Schultz-Dale Tissue Bath Vessel 
the vessel is made from a 13mm o.d., lOmrn i.d. Pyrex fine 
porosity (F) sintered glass disc. The height above the 
disc is 115mrn giving a working volume of 6-7ml. The bottom 
i s tapered to attach to Smm i.d. Tygon tubing, which 
connects to the oxygen supply. Oxygen is regulated by a 
two-stage regulator and accessory fine taper needle valve. 
The entire vessel is water jacketed and is kept at 37 + .os0 
by a circulating bath. The inside 3mm rod is held in 
position by a rubber band attached to the water outlet. 
The vessel is filled by an all glass automatic syringe or 
pipet and emptied with a 16 gauge needle connected to an 
54 
aspirator line. Test substances are added with a microliter 
syringe and are stirred by the oxygen flow. 
All glassware and surgical instruments used in Schultz-
Dale experiments were rinsed at least 3 times in glass 
distilled water a nd air dried before use. Most apparatus 
was used only for Schultz-Dale to prevent contamination by 
tissue toxic substances. Guinea pig gut is very sensitive 
to many impurities, much more so than many cell cultures. 
Procedures 
The gut was attached to the rod and to the transducer 
with silk thread and then rinsed twice with Tyrode solution. 
It was then equilibrated for 20-30 minutes at 37° and 
tested for viability with histamine. 0.01 microgram of 
histamine should give a pen deflection of at least 5mm with 
either apparatus. The normal contractions should be less 
than 50% of the histamine caused deflection. The piece was 
challenged 3 consecutive times with histamine and then 
washed and re-equilibrated for 10-15 minutes. Passive 
sensitizations were done in either Tyrode solution or 
isotonic buffered glucose for varying times from 10-60 
minutes. 30 minutes was the most common sensitization time. 
The gut was teste d with histamine and washed 3 times with 
Tyrode solution and equilibrated for 20 minutes. The gut 
was then challenged with antigen; after 4 washings and 
equilibration, it was rechallenged to test for 
desensitization and then retested with histamine. Results 
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were compared as histamine equivalents. The variation 
among different pieces of gut was usually less than a 
factor of 2 on this basis. 
D. Immunoadsorbents 
1. Para-Aminobenzyl cellulose (50) 
Machery Nagel 300 or Whatman CFll cellulose powder was 
washed in 3% NaOH, 2N HCl, water and acetone. It was then 
dried under vacuum. 2g of washed cellulose powder, 6g of 
p-nitrobenzyl chloride and 6g of NaOH in 30ml of water were 
mixed in a three neck flask equipped with stirrer, condenser 
and thermometer. The reaction was stirred at 93° for 4 
hours using a water bath to regulate the temperature. The 
mixture was then poured into 400ml of ice water, filtered 
and washed with water, alcohol and then acetone. The solid 
was then extracted with acetone for 4 days in a Soxhlet 
extractor. The yield was l.8g. 
The dried nitrobenzyl cellulose from the previous step 
was suspended in 20ml of ethanol in a three neck flask 
equipped as above. The alcohol was refluxed, and l.8g of 
sodium dithionite dissolved in the minimum amount of water 
was slowly added with vigorous stirring. The reaction was 
refluxed for 30 minutes after the addition was completed, 
and the light yellow product was filtered, washed with 
water and vacuum dried. The yield was l.7g. 
The p-aminobenzyl cellulose was coupled by 
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diazotization. lg of p-aminobenzyl cellulose was suspended 
in 2ml of 2N HCl and 4ml of water and cooled in ice. 0.5-1 
ml of 0.5M NaN02 was added until there was an excess of 
nitrite for 15 minutes when tested with starch-iodide paper. 
After stirring an additional 15 minutes, the cellulose was 
filtered and washed with 200ml of 0.3% sulfamic acid. The 
diazotized cellulose was added to lOml of 2mg/ml BSA in 
borate-saline pH 8.4 and stirred at 4° for 5 days. The 
adsorbent was filtered and washed with 300ml of borate-
saline. Free diazonium groups were blocked by stirring the 
adsorbent in 50ml of saturated ~-naphthol in borate buffer 
pH 8.7 for 30 minutes at 4°. It was then filtered and 
thoroughly washed with buffer and water. 
Adsorption and elution procedures were similar to 
those described below. The best procedure for this system 
was glycine-HCl buffer pH 2.0. 
2. Half benzidine amide of carboxymechylcellulose (51) 
lg of Machery Nagel CMC 300 was stirred in 200ml of 2N 
HCl for an hour, filtered, stirred with 400ml of water, 
filtered and washed again with water. The CMC was slowly 
added to 0.2g of benzidine in 2ml of water in a small flask 
until 0.8g of the CMC had been added together with e nough 
water to make the mixture semi-solid. 0.4g of dicyclohexyl-
carbodiimide in lml of tetrahydrofuran and lml of water 
were added along with the rest of the CMC. The creamy 
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mixture was stirred for 2 days. The mixture should not 
be dry after this. 20ml of water was added and the reaction 
mixture was poured into 400ml of dilute NaHco
3
• The final 
pH should be 8-9. After stirring overnight the mixture was 
filtered and water washed. The derivative was suspended in 
200ml of acetone for an hour and then filtered; this was 
repeated twice. The dry CMC was washed 3 times with dilute 
NaHC03 , 3 times with dilute HCl and 3 times with water. It 
was then acetone washed and vacuum dried. 
Three methods of coupling were used. Diazotization 
was performed as described for p-aminobenzyl cellulose. 
Acid chlorides were coupled by Schotten-Baumann reaction. 
The benzidine CMC was suspended in water and a solution of 
acid chloride in ether was dropped in, while the pH was 
kept at 7-9 by the addition of lN NaOH. The derivative was 
washed thoroughly with water and acetone. This reaction 
was also used with aminoethyl cellulose (Bio-Rad). The 
adsorbent could also be prepared and coupled to haptens 
by the use of Woodward's reagent (52), N-ethyl-5-phenyl-
isoxazolium-3'-sulfonate in acetonitrile. 
3. Cyanogen bromide treated agarose 
lg of cyanogen bromide in 40ml of water at pH 11 was 
added to lg of 4% agarose (Sepharose 4B, about 56ml). The 
pH was immediately adjusted to 11 and held at 11 for 6 
minutes with 2N NaOH. The solid was then immediately 
58 
washed with cold water and then O.lM NaHC03 • This product 
was immediately suspended in 30ml of O.lM NaHco3 and placed 
in a stoppered tube with 500mg of KLH in lOml of saline. 
The tube was slowly rotated end over end for 24 hours at so. 
The coupled adsorbent was then poured into a column and 
wa shed at 20ml/hour for 48 hours with borate-saline pH 8.4, 
24 hours with O.lM acetate pH 4.1 in O.lM NaCl, and 24 hours 
with O.lM a cetate pH 4.1. The gel was then washed with 
saline and used in O.lM Tris-HCl pH 7.4. Tetracycline did 
not couple under these conditions. Antibody was eluted 
using a column method with O.lM acetic acid or free hapten. 
4. Bromoacetylcellulose (54,55) 
Whatman CFll cellulose powder was washed with large 
volumes of acetone and dioxane and vacuum dried over P2o 5 . 
57g of bromoacetic acid was dissolved in 18ml of dioxane 
freshly distilled from sodium. 6g of cellulose powder was 
added, and the mixture was stirred for 22 hours in a 
stoppered flask. 43ml (lOOg) of bromoacetyl bromide 
(Aldrich, others are usually of an inferior quality) was 
added and the flask was connected to a NaOH trap and 
stirred for 9~ hours. The mixture was poured into 4 liters 
of iced distilled water and stirred for 15 minutes. It was 
then centrifuged, and the solid washed several times with 
water. The BAC was then stirred overnight in 1200ml of 
O.lM NaHco3 , filtered and washed 4 times with O.lM 
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bicarbonate by centrifuging. It was the n washed 5 times 
with water and suspended in lOOml of water. 2ml wa s vacuum 
dried. The yield was 3.7g. 
lg of BAC in 46ml was added to 400mg of RSA in 35ml 
of O.lM phosphate-0.05M citrate pH 3.8 (for KLH, pH 4.6, 
for BSA, pH 3.8). A drop of toluene was added and the 
mixture was vigorously stirred for 30 hours at room 
temperature. The mixture was then centrifuged, and the BAC 
was suspended in 30ml of O.lM bicarbona te pH 9 and stirred 
in the cold for 24 hours. The RSABAC was centrifuged and 
then suspended in 0.05Maminoethanol-0.1M bicarbonate pH 8.8 
for 36 hours in the cold. It was then centrifuged and 
washed 3 times with normal saline and then stirred with 30 
ml of BM urea for 24 hours at room temperature. The 
adsorbent was then washed with saline until the absorbance 
of the wash a t 280nm was less than 0.03. The adsorbent was 
stored in 0.15M phosphate pH 7.0 at 4°. 
lOml of antise rum or total globulins was diluted with 
lOml of borate-saline pH 8.4 a nd stirred with the adsorbent 
prepared from 0.5g of BAC, was he d twice just before use. 
The suspension was stirred for 45-120 minutes at 4°. The 
ads orbent was the n centrifuged and washe d 3 times with 
borate-saline pH 8.4 or until the absorbance of the wash 
was less than 0.04 a t 280nm. The antibody was elute d by 
stirring wi t h 25ml of O.lM acetic a cid for 1 hour at 37° or 
with g lycine-HCl pH 2.2. The a dsorbent was e x tracte d twice. 
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After centrifugation the eluate was neutralized, then 
dialyzed against dilute borate-saline buffer in saline. 
The antibody was then filtered through a 0.45 micron 
membrane filter and concentrated by ultrafiltration. 
5 . Glutaraldehyde crosslinking (56) 
250mg of BGG was dissolved in 5ml of 0.1.M phosphate pH 
7. lml of 2.5% glutaraldehyde was dropped in with stirring 
at room temperature. The resulting gel was then allowed to 
stand for 3 hours at room temperature. It was then 
homogenized in 0.2M phosphate pH 7.3 in a blendor and 
centrifuged; this was repeated 3 times and the insoluble 
polymer was then washed twice in 0.1.M glycine-HCl pH 2.2 
and twice again in phosphate. Antibody was purified as in 
4. 
6. Ethyl chloroformate crosslinking (57) 
5g of BGG was dissolved in lOOml of 0.11.M phosphate pH 
7.3 and 4ml of ethyl chloroformate was added with stirring 
while the pH was k e pt between 7.1 and 7.3. The solid 
formed in 30 minutes and was allowed to stand for an 
additional hour. It was filtered and homogenized in 2 
liters of phosphate-saline, centrifuged and washed with 400 
ml of 0.3% Na2C03, then twice with phosphate-saline, 4 
times with glycine-HCl pH 1.8, and 3 times with phosphate-
saline. BSA was polymerized in 0.1.M aceta te pH 4.5-5.0 
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and KLH at pH 6.1-6.4. Antibody was purified using the 
method given for bromoacetylcellulose. 
7. Polyacrylamide gel (58) 
7.Sg of acrylamide and 2.Sg of N,N'-methylene-bis-
acrylamide were dissolved in lOOml of 0.025M Tris-HCl pH 
7.4. 700mg of BGG in lOml of water and lml of a suspension 
containing 0.3mg of riboflavin were added. Nitrogen was 
slowly bubbled through the solution for 15 minutes and the 
flask was stoppered and then irradiated with a 100 watt 
incandescent frosted bulb. The gel polymerized in about 20 
minutes and irradiation was continued fo'r another hour. 
The gel was cut up and dispersed into 0.025M Tris-HCl in 
saline by forcing it through a syringe and then through a 
15 gauge needle. The gel was washed with the following in 
order: 4 times with Tris-saline, once with saline, twice 
with O.lM glycine-HCl pH 2.2, once with saline and twice 
with Tris-saline. It was stored in Tris-HCl O.OlM pH 7.4. 
This method works well with azo and amide coupled proteins. 
8. Sephadex 
Methods 1,3 and 4 were tried with Sephadex instead of 
cellulose and method 2 with CMSephadex, but all of the 
reactions destroyed the crosslinked dextran. 
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9. Elution 
Several elution methods were used. They included O.lN 
HCl, O.lM acetic acid, glycine-HCl buffer pH 2.2, SM iodide 
and O.lM hapten. O.lM glycine-HCl pH 2.2 at 37° was found 
t o be the best method for most systems. Free hapten is the 
best eluant for antibody against dinitrophenyl determinants. 
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Chapter II 
IMMUNOCHEMICAL STUDIES OF ASPIRIN INTOLERANCE 
A. The Rabbit Anti-Aspiryl System 
Introduction 
The existence of hypersensitivity type reactions to 
aspirin has been known since 1902 (1). However, further 
studies have accomplished little in elucidating whether 
or not the adverse clinical reactions to aspirin are due 
to antigen-antibody reactions or to some other mechanism. 
No one has yet found either a precipitating or reaginic 
type antibody in the serum of individuals who react 
adversely to aspirin. 
Weiner, Rosenblatt and Howes (2) were able to detect a 
factor in sera from aspirin intolerant individuals, which 
was able to agglutinate red cells treated with aspiryl 
proteins; this factor was destroyed by heating to 56°. 
Daniel, Perloff, Major and Baum (3) investigated patients 
treated with para-aminosalicylic acid and found an equal 
percentage of positive hemagglutination reactions among 
both individuals who demonstrated clinical sensitivity and 
normal individuals. Yurchak, Wicher and Arbesman (4) were 
unable to detect hemagglutinating antibody in sera from 
aspirin sensitive individuals using aspiryl proteins. 
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Many other attempts to detect antibodies against 
aspirin in sensitive individuals have all given negative 
results. The methods used have included direct and passive 
skin tests with aspirin (5,6,7) and with aspiryl proteins 
(4,7). Results from lymphocyte stimulation tests, 
inununofluorescent studies of nasal polyps (4) and leukocyte 
histamine release (8) were also negative. 
Two inununological mechanisms have been proposed for 
aspirin sensitivity. The first is reaction against the 
aspiryl or salicylyl moiety (2,7,9,10), and the second is 
a reaction to serum proteins acetylated by aspirin (11). 
One approach to the resolution of this problem is to select 
and study clearly defined model systems and then to apply 
this knowledge to the study of the clinical problem. One 
such system is the aspiryl hapten in the rabbit. The 
specificity and combining properties of rabbit antibodies 
against aspiryl proteins are reported and discussed in this 
section. 
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Materials and Methods 
5-Methylaspirin (12). 14ml of acetic anhydride and 5 drops 
of concentrated sulfuric acid were added to 9 grams of 
5-methylsalicylic acid (Aldrich). The mixture was kept at 
50-60° for 15 minutes, cooled and 150ml of water was added. 
The 5-methylaspirin was filtered off, vacuum dried over 
KOH and then crystallized from benzene and vacuum dried. 
The yield was 7.5g; the melting point was 146-148°. 
Aspiryl Chloride (13). 36g of aspirin, lOOml of benzene 
and 40ml of thionyl chloride were refluxed for 5 hours. 
The solvent was stripped off under vacuum and the residue 
was vacuum distilled. The boiling point was 93-94° at lrrnn. 
5-Methylaspiryl chloride was prepared similarly; its 
boiling point was 107-108° at lrrnn. 
Protein Carriers. Bovine serum albumin (BSA) and bovine 
gamma globulin (BGG) were purchased from Armour 
Pharmaceuticals, Kankakee, Illinois. Keyhole limpet 
hemocyanin (KLH) was prepared by a modification of the 
method of Campbell, Garvey, Cremer and Sussdorf (14) and 
was resedimented by centrifugation at 30,000rpm and 
redissolved before use. 
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Antigens. Conjugates were prepared by Schotten-Baumann 
reaction of acid chlorides with protein carriers. The 
procedure of Wicher, Schwartz, Arbesman and Milgrom (10) was 
followed with only minor modifications. The conjugates 
were purified by precipitation with acetic acid at pH 4 and 
were then redissolved in sodium carbonate; this was repeated 
4 or 5 times (15). The conjugates were dialyzed against 
O.OlN Na2co3 4 times, and finally 6 times against borate-
saline pH 8.4. KLH proteins are irreversibly denatured by 
acid precipitation and become insoluble. Protein 
concentrations were determined by the Nessler reaction (14) 
and the hapten was estimated by UV absorption at 350nm (the 
numbers are transposed to 305 in reference 10). AspirylBSA 
had about 16 hapten residues per protein molecule, and 
aspirylBGG had about 31. The absorption of KLH interferes 
with the determination of aspiryl groups by UV. 
Preparation of Antisera. New Zealand albino male rabbits 
weighing at least 5 pounds were injected intradermally 
in two sites with 1.25-2.Smg of antigen emulsified with an 
equal volume of Freund's complete adjuvant (Difeo). This 
procedure was repeated weekly for a total of 8 weeks and 
the rabbits were bled 10 days after the last injection. 
All sera were stored frozen. All of the precipitation and 
most of the other experiments were performed with total 
g lobulin fractions, prepared by precipitation 3 times with 
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33% saturated ammonium sulfate (14). 
Preparation of Haptens. Acid chlorides were coupled to 
t-aminocaproic acid (ACA) and d-carbobenzoxy-L-lysine 
(CBZ-Lys) by Schotten-Baumann reaction. Yields of purified 
materials were generally about 30-50% after 
recrystallization from benzene or benzene-pentane mixtures. 
All chemicals were either reagent grade or were the highest 
purity commercially available and were used without further 
purification. The identity of the compounds synthesized 
was verified by NMR spectroscopy and the purity was checked 
by melting point. The melting points are listed in table 1. 
Table 1 
Melting Points of Haptens 
'-Aspirylaminocaproic acid 105-107° 
~-R-Methylaspirylarninocaproic acid 133-1350 
£-Benzoylaminocaproic acid 
t-p-Chlorobenzoylaminocaproic acid 
~-Anisoylaminocaproic acid 
'-m-Bromobenzoylaminocaproic acid 
5-Methylaspirin 
78-80° 
98-100° 
98-101° 
119-121° 
146-148° 
Aspirin was Merck USP grade, the same grade used 
clinically. Aspirin solutions were prepared immediately 
before use, since aspirin decomposes in solution. Most 
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other solutions were also prepared immediately before use. 
Purification of Anti-Aspiryl Antibody. An immunoadsorbent 
consisting of a protein antigen trapped in a polyacrylamide 
ge l (16) was used. A mixture of 15ml of 12.5% acrylamide 
and 4.2% N,N'-methylene-bis-acrylamide, 20ml of 0.8% AspBSA 
and lml of 0.3mg/ml riboflavin under a nitrogen atmosphere 
was irradiated with a 100 watt incandescent bulb for 1 hour. 
The gel was dispersed twice through a 15 gauge needle and 
was washed 4 times with O.lM Tris-HCl buffer pH 7.4, twice 
with 0.2M glycine-HCl pH 2.2 and finally twice with Tris 
pH 7.4 after a saline wash. 23ml of anti-aspirylBGG total 
g lobulins containing 25mg of anti-aspiryl was added to the 
gel and the suspension was stirred for 30 minutes at room 
temperature. The mixture was centrifuged for 5 minutes at 
2000rpm. The supernatant gave a negative ring test with 
aspirylKLH. The solid was washed once with Tris-HCl pH 7.4 
and 4 times with saline. The absorbance of the last wash 
was less than 0.03 at 280nm. The antibody was then eluted 
with 25ml of 0.02M g lycine-HCl pH 2.2 for 30 minutes and 
again with another portion for 15 minutes. The eluant was 
f iltered through a 0.45 micron membrane filter after 
neutralization and then dialyzed 3 times against 1 liter 
volumes of borate-saline pH 8.4 and filtered again. The 
antibody was concentrated by ultrafiltration with a UM20E 
membrane. Over 75% of the protein was precipitable antibody. 
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Aspiryl-carboxyl-cl4_ACA. Aspirin-carboxyl-c14 was 
purchased from Amersham-Searle. 50 microcuries (0.55mg) 
of aspirin-cl4, l.5ml of benzene and 5 drops of thionyl 
chloride were refluxed for 5 hours. The solvent was then 
removed by vacuum distillation. The residue was dissolved 
in ether and added to lOOmg of ~-aminocaproic acid in 2.5ml 
of methanol. 30mg of aspiryl chloride was added, and the 
solution was stirred for 70 minutes. It was then diluted 
with water, acidified with acetic acid and extracted 3 
times with chloroform. The CHCl3 was extracted once with 
0.5N Na2C03 and twice with O.lN Na2C03 • The carbonate 
solution was acidified with acetic acid and extracted 4 
times with CHC13 . The CHC13 was dried with sodium sulfate 
and evaporated. The residue was crystallized from benzene-
pentane. 8mg of aspiryl-cl4_aminocaproic acid was dissolved 
in 7ml of dilute NaHC03 and diluted to 25ml with borate-
saline pH 8.4. Dilutions of 2xlo-5 to lo-7 molar were 
prepared from this stock solution using borate-saline 
buffer as diluent. The specific activity was determined by 
scintillation counting, and the actual concentrations were 
determined by radioactivity. 
Quantitative Precipitation and Inhibition of Precipitation 
Analyses. Hapten specific antibody was determined by mixing 
equal volumes (0.5 or 0.25ml) of serum globulin fraction 
with dilutions of heterologous non-cross reacting carrier 
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antigen. After standing 2 hours at 37°, the tubes were 
stored for 48 hours at 4°, centrifuged 30 minutes at 3000 
rpm, and the precipitates were washed twice with borate-
saline pH 8.4 and assayed · by Nessler reaction on a 2/5 
scale (14). Inhibition tests were performed by mix ing 0.25 
ml of antibody, 0.5ml of hapten dilution in borate-saline 
and 0.25ml of the equivalence dilution of antigen. The 
same pool of sera was used for all inhibition tests. Each 
hapten was measured in a duplicate series of 4 to 6 
dilutions. 
Equilibrium Dialysis. Equilibrium dialyses were carried out 
in a wa ter bath at 4°. The cells were ma de by cutting off 
18/9 Pyrex "O" ring joints to a capacity of 1. 5ml. The 
two halves of the cell were sealed with a teflon "O" ring 
and Saran Wrap covered rubber stoppers and were held together 
by two ball joint clamps, one of which was drilled to fit 
on an innnersible rotator driven by a fle x ible cable. The 
cell is illustrated in figure 1. The membrane was cut from 
number 36 Visking tubing that had been boiled twice in 
dilute sodium bicarbonate and 3 times in distilled wa ter. 
0.9-1.0ml of either specifically purified antibody or of 
total serum globulins was pipe tted into one side of the 
c e ll and the s ame amo unt of ha pten solution wa s pipe tted 
into the othe r side. After the cells wer e rotated a t 29rpm 
f or 48 h ours , 0.5ml s amples were taken from each h a lf of 
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the cell with volumetric pipets. Each sample was added 
to a scintillation vial containing 15ml of a fluor 
consisting of 7g of 2,5-diphenyloxazole (PPO), 0.7g of 
l,4-bis-2-(4-methyl-5-phenyloxazoyl)benzene (dimethyl-
POPOP), lOOg of naphthalene and 40g of Cab-0-Sil (Cabot 
Corporation) in lOOOml of reagent dioxane (17). The samples 
were counted for several 10 minute cycles in a scintillation 
counter. The counting efficiency was 83% for cl4. 
Serological Procedures. All sera were tested by ring tests 
with heterologous non-cross reacting carrier antigen, 
passive cutaneous anaphylaxis (PCA) (18), and innnuno-
diffusion in 1% Noble agar (Difeo) in 5% borate-saline pH 
8.4 -- 95% saline. 
Figure 1 
Equilibrium Dialysis Cell 
a - membrane 
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Results 
All rabbits immunized with aspiryl, 5-rnethylaspiryl 
and benzoyl proteins produced specific anti-hapten 
antibody in medium to high titer (0.2 - 3.0rng/ml). 
Animals immunized with antigens made with KLH as the 
carrier protein produced the most anti-hapten antibody in 
each case. BGG was not as effective a carrier, and BSA was 
significantly less effective than either of the other two. 
There was no cross reactivity between KLH and BSA and none 
between KLH and BGG. The cross reactivity between BSA and 
BGG was less than 0.1% as measured by PCA reaction in guinea 
pigs. Because of their higher titers and lack of carrier 
cross reactivity, sera produced by rabbits immunized with 
KLH conjugates were used in most experiments. 
Neither free aspirin nor aspiryl-t-aminocaproate 
(aspiryl-ACA) gave a positive PCA reaction or precipitation 
reaction as did the protein conjugates. Both haptens 
could inhibit precipitation and PCA, but aspirin was only 
effective at relatively high concentrations, i.e. greater 
than O.OlM in the inhibition system described. 
The data from quantitative inhibition precipitation 
reactions were analyzed by the method of mauling~ al. (19). 
This method assumes an error function for the distribution 
of the free energies of combination, and then the data are 
fitted to calculated curves by the use of an empirically 
determined heterogeneity index,6. The method is given in 
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detail by Pressman and Grossberg (20). The relative 
combining constant, Krel> is the ratio of the combining 
constants of test to reference haptens or the ratio of the 
fiducial concentration of the reference and test haptens. 
The relative free energies of combination, AFrel' are 
calculated at 37°. The results are given in table 2 for 
the inhibition of the reaction between anti-aspirylKLH 
and aspirylBSA at pH 8.4. 
Average binding constants, KH' were determined by 
equilibrium dialysis. The binding constants, KH, were 
assumed to be a Sips distribution about the average, KH· 
The method of treating the data was that of Nisonoff and 
Pressman (21). The reciprocal of the concentration of 
antibody sites, l/A0 , was determined by taking the intercept 
of a plot of the reciprocal of the bound hapten 
concentration, l/b, against the reciprocal of the free 
hapten concentration, l/c. In each experiment the 
extrapolated value of A0 agreed with the value determined 
by quantitative precipitation tests within the experimental 
errors. 
The average binding 
a plot of log (A0 ) 
-- 1 
b 
constant, KH, was 
against log ( ~ J . 
obtained from 
KH_ is the value 
of l/c when (A0 /b)-l equals 1, the point at which half of 
the antibody sites are occupied. The data for a ~ample 
experiment are in t ab le 3 and these data are plotted in 
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Table 2 
Inhibition of Precipitation of Anti- AspirylKLH with 
AspirylBSA 
Hap ten a 6 
Aspiryl-ACA 3.5 
5-Methylaspiryl-ACA 3 
Benzoyl-ACA 4 
~-Aspiryl-~-CBw-i-lysine 2.5 
6 - CBZ-L-lysine 0 
DNP-L-lysined 0 
p-Chlorobenzoyl-ACA 5 
Anisoyl-ACA 4 
m-Bromobenzoyl-ACA 5 
Aspirin 2 
Benzoate 1 
Salicylate 1 
4-Aminosalicylate 0 
5-Methylsalicylate 1 
5-Methylaspirin 1 
E--CBZ-L-lysine 
ACA 
a See figure 2 for structures. 
b at 37° in calories/mole 
c log fiducial concentration 
d ~-OI4-dinitrophenyl-i-lysine 
1.00 
.37 
.0058 
.73 
.044 
(.005 
.0025 
.0013 
.0014 
.00010 
.000055 
.00018 
.00017 
.00020 
.00018 
{. 0001 
(.0001 
F b 
.6 rel 
0 
610 
3170 
200 
1920 
> 3250 
3670 
4080 
4030 
5650 
6020 
5280 
5260 
5230 
5280 
> 6000 
) 6000 
log C c 
f 
-4.98 
-4~RO 
-2.73 
-4.83 
-3.60 
) -2. 65 
-2.36 
-2.06 
-2.10 
-0.96 
-0.70 
-1. 22 
-1.18 
-1. 27 
-1. 21 
> - 1.0 
)-1.0 
lE~lClCeI 
C.00"-
Aspirin 
NH, . OH 
l£-F~ 
coo-
4-Aminosalicylatc 
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OH 
· y I l l ~ K "" cocr 
Sn.Ii cy late 
EE~ElClCeI 
~ cu, cmr 
5-1\fcthyln.spirin 
(("}(OCOCH, 
CONJ I CH,CH,CH,CH,CH,coo-
·-Aspi ry lam inocaproate 
ccS!, 
'JONHCH,CH,CH,CH,CH,COO-
•-Anisoyl-ACA 
OCOCH, 
©:( 7 HCOOCH,-© 
CONHCH,CH,CH,CH,yH 
coo-
· -Aspiryl-a-CBZ-lysine 
NO, 
iR f"' 
NO, NHCH,CH,CH,CH,CH 
too-
•-2 ,4-DNP-lysine 
Figure 2 
Structures of Haptens 
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Figure 3 
Equilibrium dialysis experiment. Anti-aspirylKLH globulins 
dialyzed against aspiryl-c14-aminocaproate at pH 8.4 for 
48 hours at 4°. The data are in table 2. A0 =1.66 x 10-
5 
molar, a=l.O, Kli= 5.6+ 0.6 x 105 liters/mole. 
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figure 3. 
Dialysis experiments with aspirin-cl4 were unsuccessful 
since the binding constant was too low to measure. 
Threefold concentrated anti-aspirylKLH serum globulins 
bound less than 1% of the hapten at free hapten concentra-
tions of 5 x 10-4 to 10- 7 molar. Both sides of the cell 
contained the same concentration of hapten within 
experimental error, as is shown in table 4. 
In experiments with aspiryl-c14-ACA good results were 
obtained. The average binding constants for anti-aspiryl 
KLH serum globulins were found to be between 4 and 8 x 105 
liters/mole. In a typical experiment~reproduced in table 
3 and figure 3>the average binding constant was found to · 
be 5.6 ± 0.6 x 105 l/m. The exponent of the Sips equation, 
a, (the slope of the log-log plot) fitted by least squares 
was 1.0, which corresponds to a relatively small amount 
of heterogeneity. An experiment with specifically purified 
anti-aspiryl antibody from anti-aspirylBGG sera gave an 
average binding constant of 2.2 ± 0.6 x 1061/rn with an 
exponent of 0 . 6. 
Discussion 
Rabbits formed specific antibody against the aspiryl 
hapten, when various protein conjugates were used for 
immunization. Immunodiffusion analysis yielded results 
similar to those previously reported (9,10). 
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Table 4 
Binding of Aspirin-c14 to Anti-aspirylKLH by Equilibrium 
Dialysis . A0= 0. 40mg/ ml= 5. 4 x 10-
6 
molar, temperature 40. 
Counts per Minute 
Dilution Free Side Antibody Side ''Binding' ' a 
1 730000 731000 + 
731000 711000 
2 395000 400000 + 
388000 396000 + 
5 161000 156000 
150000 155000 + 
10 80000 79000 
75700 77300 + 
20 39900 39300 
38500 38200 
50 15800 16100 .. 
a sign of antibody side cpm minus free side cpm 
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At the pH used in these studies, 8.4, it is very 
probable that most of the compounds referred to in the 
text as aspiryl are partially hydrolyzed and are actually 
mixtures of salicylyl and aspiryl compounds. The haptens 
are not soluble in neutral or acidic aqueous solutions. 
However, blood is slightly basic, so the experimental 
situation probably reflects the physiological situation. 
The inhibition of precipitation experiments showed 
that aspiryl-ACA was the most effective inhibitor of the 
haptens tried. It was even more effective than f-aspiryl-~­
CBZ-L-lysine, the hapten which in some ways most closely 
approximates the combining part of the protein antigen; 
although the relative free energy difference was only about 
0.2 kcal/mole. This order of reactivity has also been 
observed with 2,4-dinitrophenyl haptens (23). The aspiryl-
aminocaproate is smaller at the carboxyl end and can 
probably fit in the antibody site in more conformations 
than the CBZ-lysine haptens. The b-aspiryl-~-CBw-lysine 
has significantly fewer stable conformations in solution 
because of the large CBZ group and the presence of an 
additional functional group which can be involved in 
hydrogen bonding. Lysine haptens can also form internal 
hydrogen bonds with the free amino group. The most stable 
conformations of the lysine haptens in solution may be 
significantly different from their conformations in protein 
antigens. It is known that hydrophilic groups like the 
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t-amino group of lysine or the aspiryl-amide generally 
stick out from globular proteins (22), so the actual 
determinant can be more closely approximated by aspiryl-ACA 
than by aspiryl-lysine. 
The fit of the antibody combining site around the 
aspiryl part of the hapten does not seem to be particularly 
close. Addition of a 5-methyl (meta to carboxyl) group to 
aspiryl-ACA causes only a 3 fold decrease in inhibitory 
power. However, the acetyl or hydroxyl group is very 
important; benzoyl-ACA is about 160 times less effective 
than aspiryl-ACA in inhibiting precipitation. If one adds 
a para-chlorine, the effectiveness is reduced again by a 
factor of 2; para-methoxy and meta-bromo groups each 
cause a 4 fold decrease in effectiveness beyond that of 
benzoyl-ACA. ~-CBw-i-lysine is 1/25 as effective as aspiryl-
ACA and 7 times more effective than benzoyl-ACA. The 
structural formulas of the aspiryl, benzoyl and CBZ groups 
show that the spatial arrangement of the CBZ group is in 
many ways between those of the aspiryl and benzoyl groups . 
The K 1 for ~-CBw-lysine is more than 10,000 times less re 
than that of aspiryl-ACA and more than 440 times less than 
that of c-CBZ-lysine. This indicates tha t the carbon 
chain is a n extremely important part of the determinant. 
Aspirin, 5-methylaspirin, salicylate, 4-aminosalicylate 
a nd 5-methylsalicylate were all 5000 to 10,000 times less 
effective in inhibiting precipitation than a spiryl-ACA. 
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This is consistent with the observations of Butler et al. 
(9). The difference between salicylate and benzoate 
still rema ins, although its magnitude is reduced to only a 
factor of 2. Feinberg and Malkiel (7), Storm van Leeuwen 
and Drzimal (24) and Lester, Lolli and Greenberg (25) all 
measured salicylate binding to sera and all obtained 
variable results indicating an easily reversible, weak 
binding of small amounts. In this study threefold 
concentrated serum globulins containing specific antibody 
bound only small amounts of aspirin-cl4; the amounts bound 
were of the order of the experimental uncertainty. 
The ave rage binding consta nt of pooled anti-aspiryl 
KLH g lobulins to a s piry l-ACA was found to be 5.6 t 0.6 x 
105 liters/mole. The constant for specifically purified 
anti-aspirylBGG was 2.2 ± 0.6 x 106 liters/mole. Both of 
these are within the normally observed r ange of antibody-
hapten binding constants. For purposes of comparison the 
values of the average binding constant for the binding of 
DNP-lysine to anti-DNP r a n ge f rom 0.4 to 8.7 x 105 liters/ 
mole according to Eis en and Sis kind (23). No high a ffinity 
antibody with average binding constants o f 107 to 108 as 
is found for DNP (23) was observed, although immunizations 
were carrie d out with small amounts of pro tein, 1.25 to 2.5 
mg per injection. 
In the rabbit anti-aspiry l s ystem the antigenic 
determina nt is close l y a pprox ima ted b y 6- aspiry l-amino-
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caproate and is probably in large part ~-aspiryl-lysylK 
Aspirin and salicylates bind very poorly to the specific 
antibody and must be present in high concentration to 
inhibit precipitation. The ortho-acetyllor at least the 
ortho-hydroxyl group~is important in the combination of 
antigen and antibody. Average binding constants for aspiryl 
ACA were between 4 and 22 x 105 liters/mole. 
Conclusions 
Anti-aspiryl antibodies were produced in rabbits using 
three protein carriers. The method of inhibition of 
precipitation was used to determine the specificity of 
the antibody produced. £-Aspirylaminocaproate was found 
to be the most effective inhibitor of the haptens tested, 
indicating that the combining hapten of the protein is 
~-aspiryl-lysylK All aspiryl haptens are actually mixtures 
of aspiryl and salicylyl derivatives. Free aspirin and 
salicylates were poor inhibitors and did not combine with the · 
antibody to a significant extent in equilibrium dialysis 
experiments. The ortho group in aspiryl and salicylyl 
amides was found to participate in the binding to antibody. 
The average binding constants of antibody globulins and 
specifically purified globulins were found to be in the 
usual range of hapten-antibody binding constants, when 
measured with aspirylaminocaproate. 
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B. Model Studies of the Acetylation Mechanism for Aspirin 
Intolerance 
Introduction 
It has recently been shown that aspirin (acetyl-
salicylic acid) can acetylate human serum proteins under 
in vitro (11) and in vivo (26) conditions. Both in vitro 
(27) and in vivo (4) studies have shown that the aspiryl/ 
salicylyl model is not relevant to the clinically observed 
syndrome, although salicylyl proteins are known to form 
under in vivo conditions (28). The determinant in the 
aspiryl/salicylyl conjugates is aspiryl/salicylyl-lysine, 
and free aspirin and salicylates are bound very weakly by 
antibodies made against this determinant; Ku is less than 
100 liters/mole (27). 
Aspirin has been found to acetylate human serum albumin 
in a reproducible manner at specific locations (26). 
Antibody against acetylated proteins has been found in both 
control and aspirin intolerant individuals after they were 
g iven aspirin orally (29). The sera from rheumatic patients 
who had received extensive aspirin therapy almost all 
contained anti-acetylated serum albumin antibodies. 
In these studies rabbits were used as a model to study 
the ease of protein acetylation by aspirin and the 
immunogenicity of the s e acetylated proteins. 
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Materials and Methods 
Acetylated Antigens. 25ml of 1M NaHC03 or 1M KzHP04 was 
added to 25ml of normal rabbit serum and cooled to 4°. 
2.5ml of acetic anhydride was dropped in, keeping the pH 
between 7 and 8 with 2N NaOH. After stirring for an 
hour, the acetylated rabbit serum antigen was dialyzed. 
lg of rabbit serum albumin (Pentex) was dissolved in 
30ml of 1M hOe~M4 and reacted as above with l.5ml of acetic 
anhydride (30). 
Aspirin Treated Sera. 25ml of 1M NaHC03 containing lg of 
aspirin was added to 25ml of each normal rabbit serum. The 
pH was 7.5-7.7. Each sample was filtered through a sterile 
0.45 micron membrane filter and then incubated for 5 days 
at 37°. Each serum antigen was extensively dialyzed against 
normal saline, pH 8.4. A second series of antigens was 
prepared using saturated aspirin in a saturated sodium 
bicarbonate solution. 
Immunization (31). Aspirin treated or acetylated serum 
antigens were prepared from pre-immunization sera from each 
of the rabbits used. Each rabbit received antigen made from 
its own serum, except those immunized with acetylated rabbit 
serum albumin, which was made from a purified product. 
0.5ml samples of each antigen at the concentrations resulting 
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after dialysis (approximately 40-50% of normal serum 
concentration) were emulsified with 0.6ml volumes of 
Freund's complete adjuvant and injected intradermally in 2 
sites in each animal. This was repeated in 14 days. The 
animals were bled 14 days later. 
Animals. The rabbits were all New Zealand albino males, 
obtained in California. They weighed at least 2kg at the 
time of immunization. Guinea pigs were albino, Campbell-
Trapani strain, bred in the Caltech closed colony. PCA 
animals we ighed about 250g. 
Precipitation Tests . Antigen and antibody were measured by 
the quantitative precipitin test, set up as previously 
described. Precipitates were quantitated by measuring 
the absorbance at 280nm after dissolving them in 3ml of 
O.lN NaOH. The absorbance of lmg/ml of RSA was found to be 
0.67, and the absorbance of lmg/ml of rabbit antibody was 
assumed to be 1 . 55. 
Passive Cutaneous Anaphylaxis. PCA was performed as 
previously described. Sera were diluted with 4 parts of 
sterile normal saline. Saline and normal serum controls 
a lways gave nega tive tests. 
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Results and Discussion 
All of the aspirin treated sera precipitated with anti-
acetylated rabbit serum, anti-acetylated rabbit serum 
albumin and anti-acetylated bovine gamma globulin. The sera 
treated with saturated aspirin in sodium bicarbonate were 
largely irreversibly insolubilized, so quantitative 
determinations of the acetylated protein in them was not 
possible. When injected into rabbits in Freund's complete 
adjuvant, each serum antigen stimulated the production 
of anti-acetylated protein antibody, which reacted with 
acetylated rabbit serum albumin and acetylated bovine gamma 
globulin. The amount of immunologically precipitable 
acetylated protein in the aspirin treated sera was quite 
small and was near the limit of detection of the precipitin 
test, so the results were verified by comparing ring tests 
of them with a series of rings prepared with known 
concentrations of acetylated rabbit serum albumin. Antibody 
was determined by quantitative precipitation tests. The 
anti-acetylated protein antibody was shown to be IgG by 
immunoelectrophoresis of a concentrated sample. The results 
of the acetylated protein and the anti-acetylated protein 
antibody determinations are given in table 5. In all cases 
controls with pre-immune, untreated sera were negative. 
The amount of acetylated protein measured by this procedure 
is a lower limit, since precipitation tests only detect 
multivalent antigen. 
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The cross reactivity of the anti-acetylated protein 
antibody with aspirylKLH (keyhole limpet hemocyanin) was 
measured by PCA reaction. The strongest reaction was 
given by an antiserum prepared against acetylated rabbit 
serum albumin; anti-aspirin treated serum antisera gave 
weaker, although still positive reactions. These results 
indicate that aspirylKLH acetylates itself upon standing. 
Very little anti-aspiryl/salicylyl antibody is produced 
by immunization with aspirin treated sera; since aspiryl/ 
salicylyl proteins are potent antigens, this would indicate 
that there is significantly less aspiryl/salicylyl protein 
than acetylated protein in the aspirin treated sera. 
Aspirin easily acetylates serum proteins under in 
vitro and in vivo conditions. Acetylated proteins are 
extremely potent antigens in rabbits; as little as 2 
micrograms of precipitable acetylated proteins can stimulate 
the production of O.lmg/ml of precipitating antibody, when 
divided into 2 injections in Freund's adjuvant. 
Samter and Beers (32) have studied the possibility 
that aspirin intolerance is not an immune reaction. The 
ease of protein acetylation by aspirin and t~ 
irnmunogenicity of acetylated proteins would lead one to 
expect that aspirin intolerance would be a corrnnon result of 
aspirin ingestion, if acetylation were the mechanism of 
aspirin intolerance. The binding properties of the 
aspiryl/salicylyl system indicate that this is not the 
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mechanism of aspirin intolerance, since salicylates combine 
as well as aspirin and the specificity of anti-aspiryl/ 
salicylyl-lysine is quite broad. The symptoms of aspirin 
intolerance are not produced in sensitive individuals by 
propionylsalicylic acid, salicylic acid, or by diacetyl-
fluorescein, an easily detectable acetylating agent. In 
some intolerant patients ingestion of other analgesics 
can cause the same symptoms as ingestion of aspirin (32). 
Further studies to elucidate the mechanism of aspirin 
intolerance require further investigation with aspirin 
intolerant human subjects. 
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Chapter III 
IMMUNOCHEMICAL STUDIES OF CONTACT DELAYED TYPE 
HYPERSENSITIVITY TO ASPIRIN IN GUINEA PIGS 
Introduction 
The clinical syndrome of aspirin intolerance does not include 
the classical symptoms of delayed hypersensitivity, such as fever 
and a latent period of more than six hours after exposure. 
However, the facile formation of aspiryl/salicylyl (1) and acetyl (2) 
proteins in vivo from aspirin fulfills one of the conditions 
necessary for the production of contact hypersensitivity. In order 
to study these systems guinea pigs were injected with aspiryl 
chloride in oil for the aspiryl/salicylyl system and with both 
acetic anhydride and acetyl chloride in oil for the acetylation 
system. In addition> guinea pigs were injected intradermally 
with various amounts of aspirin to find out if contact sensitivity 
could be induced. 
Contact sensitivity has been extensively investigated with 
both the dinitrophenyl (DNP) and trinitrophenyl (TNP) systems in 
guinea pigs (3). Several efficient methods of sensitization have 
been developed (4, 5} which require only a few micrograms of 
sensitizer. The hypersensitivity is caused by conjugates, which 
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are formed from the in vivo reaction of the sensitizer with body 
proteins to form an antigenic foreign protein. The specificity of 
contact sensitivity is similar to that of delayed hypersensitivity 
induced by the injection of hapten protein conjugates (6) and in most 
cases involves carrier as well as hapten specificity. 
Materials and Methods 
Materials for Immunization and Skin Testing. 
Freund's adjuvant, complete.., and also dried Mycobacterium 
butyricum were obtained from Difeo. Marcol 52 was purchased 
from Humble Oil Company and olive oil was purchased in a local 
supermarket. Other solvents were reagent grade. 
It was found that when Marcol or Freund's adjuvant was used 
for immunization, skin tests with Marcol produced positive reactions. 
In these cases olive oil was used as the test vehicle. It was also 
necessary to clean apparatus used for preparing Freund's emulsions 
meticulously, since traces of protein as small as 0. 001 microgram 
can induce delayed hypersensitivity. 
Immunization. 
1. Each animal was injected with 0. 05ml of Marcol or olive oil 
containing 5 micrograms of acid chloride intradermally on 10 
consecutive days. After resting for 14 days the animals were tested. 
99 
This method was used in early experiments. 
2. 5 skin sites on the flank of each guinea pig were injected with 
0. 05ml of olive oil containing 2. 5 micrograms of sensitizer ( a total 
of 12. 5 micrograms per animal). After 90 minutes the same sites 
were injected with another 0. 05ml of oil containing 2. 5 micrograms 
of heat killed dried Mycobacteria. The animals were tested at 
days 13, 20 and 27. The injection sites usually become partially 
healed in the first few days, and then open sores form coincident 
with the appearance of reactivity to tuberculin (5). This is a split 
adjuvant technique. 
3. Freshly prepared aspirin solutions in pH 8 buffer were emulsified 
with Freund's complete adjuvant. Each animal received intradermal 
injections of 0. lml each in 5 sites and was tested on days 14 and 21. 
Skin Tests. 
OU soluble sensitizers were applied in olive oil with a 
disposable Pasteur pipet, generally at a concentration of 1 %. The 
guinea pigs were carefully shaved with a number 000 electric 
clipper and one drop of test solution was spread on the skin. The 
skin was only touched with the smooth area of the pipet and rubbing 
was only with the grain of the hair. 0. lml of water soluble 
sensitizers were injected intradermally for challenge. All challenge 
solutions were tested on unsensitized guinea pigs to determine if 
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they caused non-specific irritation. Some animals were tuberculin 
tested to provide a positive control. A few experiments were tried 
using dimethyl sulfoxide, methyl ethyl ketone and propylene glycol 
as contact testing solvents. 
The reactions were read at 6, 24 and 48 hours. They were 
graded as follows; _., faint pink; "'+, pale pink; ttt, pink; t+++, 
pink and thickened. Readings were verified by several observers, 
who were not informed of the substances used, but only of the number 
and approximate location on each animal. Most of the reactions 
were evaluated equally by several observers; at most there was a 
variation of one degree among the observers. 
Passive Cutaneous Anaphylaxis. 
PCA was performed as previously described, except that the 
latent period was 18 hours, which is required for maximal 
sensitization with guinea pig antibody (4). 
Arthus Reactions. 
Arthus reactivity was measured by intracardiac injection of 
0. 5ml of 1 % Evans blue followed by intradermal injection of O. lml 
of antigen using a 30 gauge special intradermal bevel needle. 
Only actively sensitized animals were used. Positive reactions were 
maximal within less than 4 hours. Arthus reactions were 
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distinguished from anaphylactic reactions by performing PCA tests. 
Sensitizers. 
The preparation of aspiryl chloride and 5-methylaspiryl 
chloride are described in chapter II. The other acid chlorides were 
all the best available commercial grade. In some cases the acid 
chlorides were vacuum distilled. 
Acetyl Guinea Pig Serum. 
3ml of normal guinea pig serum was added to 3ml of 1 N 
NaHC03 and cooled in ice. 0. 3ml of acetic anhydride was dropped in 
with stirring over a period of 30 minutes. After standing an 
additional hour, the antigen was dialyzed against saline containing 5% 
borate-saline buffer pH 8. 4. The concentration of the stock solution 
was 13. 8 mg/ ml. 
Guinea Pigs. 
Guinea pigs were all Campbell-Trapani strain albinos, bred 
in the Caltech closed colony. Animals from 250-500 grams were 
used for both PCA and contact tests. Adult and older animals gave 
less consistent results in contact tests. 
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Results and Discussion 
Every guinea pig immunized with aromatic acid chlorides by 
either method developed contact sensitivity. The first experiments 
were done using 10 daily injections without Mycobacteria (4) and 
later experiments were done using 5 simultaneous injections followed 
by Mycobacteria (5). Both methods gave similar results, but the 
split adjuvant technique was easier experimentally and allowe d 
results to be obtained in less time. Testing with the immunizing 
hapten acted as a booster injection. This effect is shown in table 1 
along with the effect of Mycobacteria. Animals immunized with 
aspiryl chloride, using either method, gave negative PCA and Arthus 
reactions at day 14. After tests on day 14 some animals gave 
positive PCA tests at day 21 when tested with aspiryl KLH. Both 
PCA and Arthus reactivity are caused by lgG antibodies, although 
only electrophoretically fast moving guinea pig lgG can cause 
homologous anaphylactic sensitization. Mycobacteria and oil 
stimulate the production of homocytotropic antibody in guinea pigs {8). 
Passive s ensitization with guinea pig homocytotropic antibody is 
maximal at 17-18 hours rather than at 3-4,as with rabbit antibody (4). 
Contact tests were performed with 1 % solutions of acid 
c hloride in olive oil. A 1 % solution of aspiryl chloride gave an 
average +++-t r eaction. The effec t of concentration is shown in 
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Table 1 
Booster Effects of Contact Testing 
Sensitizer Test at Day 14 2nd Test at Day 21 
Benzoyl Chloride 
o-Chlorobenzoyl Chloride 
p-Chlorobenzoyl Chloride 
5-Methylaspiryl Chloride 
++ 
+t 
++i 
Aspiryl Chloride (Mycobacteria) +'tt,., t1"tb 
Aspiryl Chloride (lOx) ·Ht, t 
a. average of three animals 
b. 2 experiments, 4 animals each 
Table 2 
t-t 
t++ 
+·H-t 
f.-+++ 
PCA -
PCA -
Effect of Concentration of Test Antigen on Contact Tests 
Test Average of 4 Animals 
1 % Aspiryl Chloride + ·t't t 
O. 1 % Aspiryl Chloride +-+" 
0. 01 % Aspiryl Chloride "+ 
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table 2. 1 % solutions of each test hapten were non-irritating to 
normal guinea pig skin. Olive oil was used as a test vehicle 
because both both Freund' s complete adjuvant and Marco! contained 
an impurity which sensitized guinea pigs, so that contact tests gave 
an average ++ reaction. 
A series of experiments summarized in table 3 was 
undertaken to determine the cross reactivity of guinea pigs 
immunized with aspiryl chloride against other aromatic acid 
chlorides, and also the specificity of delayed reactions in guinea 
pigs sensitized with these other haptens. Guinea pigs sensitized 
with aspiryl chloride gave weaker reactions to 5-methylaspiryl 
chloride, para-chlorobenzoyl chloride and ortho-chlorobenzoyl 
chloride, the reaction was much weaker to benzoyl chloride, 
but it was still clearly positive. The specificity is quite broad; 
but apparently there are some limitations due to steric factors 
as well as to chemical factors. The binding in the site is 
apparently quite loose since a 5- (meta) methyl can . be 
accomodated in addition to the ortho-hydroxyl. The reactions with 
both the para and ortho-chloro compounds were approximately 
equal. The significantly smaller benzoyl chloride reacted mµy 
weakly. 
Benzoyl chloride was a significantly less potent sensitizer 
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Table 3 
Cross Reactivity of Aromatic Acid Chlorides in Contact Sensitivity 
Immunized with Tested with 
Asp Cl BenCl o-ClBenCl p-ClBenCl 5-MeAspCl Con 
24 hour observation 
AspCl + ... + + + 1/2 + ~+ 
BenCl 1/2"' +-t+ t' .. .,. ++ 1/2 + 
o--ClBenCl 1/2 + + +-++t + 
p-ClBenCl ++ +1 +-+++ 
5-MeAspCl +++ ... + + •+t 
Control 
48 hour observation 
AspCl +++ + + + ++ ++ 
Ben Cl t.,. +tt t-+t +++ + 
o-ClBenCl +-t +-t- ++t +~+ 1/2 + 
p -ClBenCl + ++1 +-++ +-+++ + 
5-MeAspCl +++ +-+t ++t +-+ ++++ 
Control 
Each reading is the average of 3 animals. The animals were sensitized 
by injection with Mycobacteria at day 0, contact tested with the 
immunizing antigen on day 14 and tested on day 21. 
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than the other compounds tested. Guinea pigs immunized with it do 
not react as strongly with aspiryl and 5-methylaspiryl chlorides as 
with the substituted benzoyl chlorides. Ortho-chlorobenzoyl chloride 
reacts more strongly than para-chlorobenzoyl chloride, indicating a 
close fit around the para position. 
Para-chlorobenzoyl chloride is a very potent sensitizer. 
The test haptens reacted in the following order: p-chlorobenzoyl 
> o-chlorobenzoyl ~ benzoyl > 5-methylaspiryl ~ aspiryl. Ortho-
chlorobenzoyl chloride sensitized guinea pigs reacted i ·n the 
following order: o-chlorobenzoyl ~ p-chlorobenzoyl > benzoyl ~ 
aspiryl > 5-methylaspiryl. In this case both chemical and steric 
factors are involved. The ortho-hydroxyl group interferes with 
the combination of the aspiryl haptens. Para-chlorobenzoyl 
chloride has a significantly different shape than the sensitizer, 
' 
o-chlorobenzoyl chloride, but it still combines more strongly 
than the ortho substituted aspiryl chloride. The 5-methyl group 
in the 5-methylaspiryl sterically interferes with the combination 
in o-chlorobenzoyl sensitized animals. 
Aspiryl conjugates of KLH, BGG and BSA gave either 
negative or very weak reactions in aspiryl c.hloride sensitized 
guinea pigs when observed at 15 minutes and 2, 6, 24 and 48 
hours after challenge. The existence of carrier specificity and 
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the relatively low degree of hapten specificity are similar to the 
specificity observed in delayed hypersensitivity to pre-formed 
hapten-protein conjugates (6, 7). The relative amounts of hapten and 
carrier specificity differ in various systems studied by other 
investigators (6, 7, 9, 10). 
If this type of sensitivity were present in human subjects, 
it would be easy to detect because of its broad specificity. 
Human beings are significantly more susceptible to contact 
sensitization than guinea pigs, because of the greater vascularization 
of human skin. Human skin has been estimated to be about 1000 
times more sensitive to DNP than guinea pig skin. Aspiryl chloride 
would probably be a relatively potent sensitizer of people exposed to 
it. Fortunately, it is a rare chemical. Attempts to sensitize guinea 
pigs with aspirin are discussed below along with the possibility of a 
contact reaction due to acetylation. 
Two groups of four guinea pigs were immunized with 12. 5 to 
25 micrograms of acetyl chloride and acetic anhydride by the split 
adjuvant technique. Mar col was used as a vehicle because it is 
relatively anhydrous. Another group was immunized with aspiryl 
chloride for comparison. The animals were contact tested on days 
14 and 20 and tested by injections of acetylated proteins on day 20. 
The results are given in table 4. On day 14 the tests were performed 
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Table 4 
Attempted Sensitization to Acetyl Proteins 
Immunization 5 x 2. 5 micrograms in 0. 05ml Marcol and 2. 5 micro-
grams of Mycobacteria in 0. 05ml Marcol. Each result is the average 
of 5 guinea pigs. 
Day 14 
Test 
Acetic Anhydride 1 % 
Acetic Anhydride Acetyl Chloride 
Acetyl Chloride 1 % 
p-Chlorobenzoyl Chloride 1 % 
Aspiryl Chloride 1 % 
Day 20 
Acetic Anhydride 5%, 10% 
Acetyl Chloride 5%, 10% 
Aspiryl Chloride 1 % 
Acetyl Guinea Pig Serum O. 1 % 
AspCl 
+ 
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with 1 % solutions in olive oil. All 12 animals as well as a control 
animal tested negative with both acetic anhydride and acetyl chloride 
at concentrations of 1 %,and on day 20 with 5 and 10% solutions. None 
of these solutions were non-specifically irritating. The guinea pigs 
immunized with aspiryl chloride tested positive with 1% aspiryl 
chloride and p-chlorobenzoyl chloride, but were negative with acetyl 
chloride and acetic anhydride. All tests with acetylated proteins were 
negative. Both 0. 1 % acetylated RSA and 0. 1 % acetylated guinea pig 
serum were tried. A couple of animals gave positive results 
with acetylated RSA, but also tested positive with a similar 
concentration of RSA. Both acetic anhydride and acetyl chloride 
are more easily hydrolyzed than the aromatic acid chlorides used, 
but they react more rapidly with free amino groups of proteins than 
with water. Acetic anhydride should be able to react with guinea pig 
skin proteins under the conditions used for immunization and testing. 
So the problem is the absence of induction of delayed hypersensitivity~ 
not the lack of production of protein conjugates in vivo. 
Aspirin was dissolved in water by adding the minimum amount 
of NaHC03 necessary to dissolve it just before it was emulsified with 
Freund's complete adjuvant. Each animal received 5 simultaneous 
injections, each of 0. 05ml containing either 5 or 25 micrograms of 
aspirin. The experiments are summarized in table 5. The tests 
1. day 0 
day 17 
day 23 
day 31 
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Table 5 
Attempted Sensitizations With Aspirin 
immunize 5 x 5 micrograms aspirin in 0. 05ml 
test with 20% aspirin in DMSO irritant 
20% in propylene glyc ol 
20% in methyl ethyl ketone 
inject 1 % in water 
test by i. d. injection 
2% aspirin in water 
1 % aspirin in water 
0. 1 % aspirin in water 
1 % a cetylated RSA + 
1 % aspiryl KLH 
1% RSA ... 
1 % acetylated BGG 
2. day 0 immunize as in 1. 
day 14 test by i. d. injection 
0. 1 % aspirin 
1% RSA 
0. 05% aspiryl KLH 
0. 1 % acetyl RSA 
continued 
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Table 5, Continued 
O. 01 % acetylated RSA 
O. 1 % acetylated BGG 
day 21 contact test with 1 % aspiryl Cl 
inject 0. 1 % aspirin 
3. day 0 immunize 5 x 25micrograms aspirin in 0. 05ml 
day 14 test by i. d. injection 
0. 1 % aspirin 
O. 1 % acetylated guinea pig serum 
0. 01 % acetylated guinea pig serum 
with aqueous solutions were all performed by intradermal injection of 
0. lml. Some of the solutions produced non-specific reddening of 
the skin so a control animal was used with each set of tests. Only 
reactions significantly larger or redder than those on the control 
animal were graded as positive. There is necessarily a subjective 
element in these evaluations. 
A series of contact tests with aspirin in dimethylsulfoxide 
(DMSO}, propylene glycol and methyl ethyl ketone were attempted. 
Dimethylsulfoxide caused non-specific reddening and increased 
vascular permeability, which was observed in guinea pigs that had 
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received Evans blue intravenously. Dimethylsulfoxide was selected 
because of its ability to carry small molecules through the skin. 
Tests with the other two solvents w·ere uniformly negative. Both 
propylene glycol and methyl ethyl ketone have been used successfully 
for contact testing with human patients. 
Tests with aspirin solutions, aspiryl KLH, acetylated RSA, 
acetylated BGG and acetylated guinea pig serum were all negative in 
all animals in which the carrier proteins tested negative. Aspirin 
solutions from 0. 1 % to 2% were used. Higher concentrations caused 
significant irritation to the skin of normal animals. One group of 
animals was tested with 1% aspiryl chloride in olive oil. All of these 
reactions were also negative. 
Aspirin did not induce either contact or delayed sensitivity 
when guinea pigs were immunized using conditions that induce 
sensitivity with other reactive compounds. The acetylation mechanism 
is not relevant to this type of hypersensitivity, since contact 
sensitivity is not produced in guinea pigs by strong acetylating agents 
like acetyl chloride and acetic anhydride. Aspiryl chloride, a 
totally artificial system, is a good sensitizer and behaves in the 
manner previously reported for other delayed and contact hapten 
systems. 
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Chapter IV 
IMMUNOCHEMICAL INVESTIGATIONS OF IMMEDIATE AND 
DELAYED HYPERSENSITIVITY TO Para-AMINOSALICYLIC ACID 
IN ANIMALS 
Introduction 
Para-aminosalicylic acid is commonly used in the treatment 
of tuberculosis and leprosy. Lehmann (1) found that p-amino-
salicylic acid inhibited the growth of Mycobacterium tuberculosis 
in vitro, but later it was found that p - aminosalicylic acid was 
not particularly effective in vivo when compared to other anti-
Mycobacterial drugs like streptomycin (2). Although streptomycin 
and Isoniazid (isonicotinic hydrazide) are usually used for primary 
treatment of tuberculosis, p-aminosalicylic acid is often used as as 
adjunct to therapy, because of its action in greatly reducing the rate 
of appearance of streptomycin resistant strains in both laboratory 
animals (3, 4) and human patients (5). 
Normally a dose of about 4 grams is administered orally. 
The free acid is found at a concentration of 3 - 12mg% in the blood 
1-1/ 2 to 2 hours after administration. The sodium salt is 
absorbed even more rapidly. Within 10 hours over 85% of the 
drug is excreted in the urine. In man more than half of the drug 
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that is excreted is acetylated. The retained drug is found in the 
kidneys, lungs and liver and a significant amount is bound by 
serum proteins (6, 7). 
Para-aminosalicylic acid is slightly soluble in water, and 
the free acid readily decarboxylates in aqueous solution to form 
meta-aminophenol. The sodium salt is very soluble and is more 
stable, although it decarboxylates upon heating (8). 
An allergic reaction to p-aminosalicylic acid was first 
reported in 1949 (9). A large number of cases have since been 
reported. A 1960 review (10) tabulates 229 well documented 
cases, most of which were verified by the administration of a 
second dose after the reaction once occurred. The clinical doses 
used have ranged from 1 to 20 grams per day. Incidence of all 
forms of allergy to this drug has been estimated to be from 0. 3 
to 5 per cent of the patients treated with the drug. At least 
three distinct types of hypersensitivity to p-aminosalicylic acid 
have been observed. Each of them is discussed separately 
below, since they appear to have different mechanisms. 
The most common form of hypersensitivity to p-ami no-
salicylic acid is completely described by Simpson and Walker (10). 
The usual symptoms are fever and a non-urticaria! skin rash; 
abnormal lymphocytes, disturbed hepatic function, leukocytosis 
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and eosinophilia can also be observed in many cases. Many 
other symptoms have been associated with this syndrome in 
individual cases. Many patients also demonstrate sensitivity to 
streptomycin and Isoniazid simultaneously. In more than half of 
the reported cases symptoms appeared between 15 and 35 days 
after the start of p-aminosalicylic acid therapy. A second 
challenge dose, administered after recovery from the symptoms 
caused by the original drug treatment, caused a recurrence of 
the symptoms. Desensitization has been reported in many cases. 
This form of hypersensitivity is considered to be of the delayed 
type, although there is no direct evidence such as observations of 
the lack of transferability by serum. This classification is made 
on the basis of the symptoms and also the presence of 
Mycobacteria, which act as an adjuvant to stimulate delayed 
hypersensitivity. 
A second type of hypersensitivity observed with p-amino-
salicylic acid is allergic contact dermatitis (11). This reaction 
is probably related to the fairly common " p-amino group " 
sensitization, which is elicited in many individuals by a variety 
of p-amino compounds. The reaction elicited by p-aminosalicylic 
acid may actually be a cross-reaction caused by sensitization to 
p-aminobenzoic acid, p-phenylenediamine, procaine or some 
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other similar compound. The cross-reactivity of patients 
sensitized to various p-amino compounds is quite wide and 
unpredictable. After extensive studies, Mayer (12) has proposed 
a mechanism for this type of hypersensitivity. His scheme for 
p-aminobenzoic acid is shown in figure 1. Mayer considers the 
reactive substances to be quinonediimines and quinoneimines. In 
a series of guinea pigs sensitized with p-phenylenediamine, tests 
with the sensitizer produced a +""t1 reaction, and tests with 
quinonediimine produced a +-K-+-+-+~ reaction. Other quinone forming 
compounds usually gave positive reactions, and non-quinone 
formers gave negative reactions. Meta-aminophenol was 
considered a non-quinone former. 
© 0 
0 
---+ ___, ---7 
COOH OH ~ 0 \ NHOH ? 1' NH © 0 
0 
Figure 1. Scheme for the formation of reactive intermediates 
from p-aminobenzoic acid (12). 
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The third type of hypersensitivity reaction to p-amino -
salicylic acid is hemolytic anemia (13, 14). Most of the cases 
reported have been from France and North Africa. Several 
authors have reported that the solutions used in these areas were 
many times discolored and contained from 2. 6 to 17% m-amino-
phenol and up to 58% of a black tarry compound (15, 16). Both of 
these substances have been accused of being the cause of t he 
hemolysis. In a few cases glucose-6-phosphate dehydrogenase 
deficiency has been demonstrated in the red cells of the hemolytic 
anemia patients (17). Deficiency of this enzyme many times 
causes drug induced hemolytic anemias (14). The enzyme 
deficiency disease is found in two forms, both of which are 
hereditary and most commonly found in areas of Africa and 
Mediterranean Europe . However, a few cases have been found in 
which the hemolytic anemia is definitely caused by p-amino-
salicylic ac id. Dausset and Bergerot-Blondel (18) extensively 
investigated a case in which hemagglutination, but not hemolysis, 
took place. They found a serum antibody which could agglutinate 
erythrocytes, leukocytes and platelets, but which did not fix 
complement. It appeared to be in the T'G fraction of the serum. The 
specificity of this antibody was determined by passive hemagglutin -
ation. Their results are given in table 1. Dausset and Thie rfelder 
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Table 1. Specificity of Antibody against p-aminosalicylate (19) 
Compound 
p-aminosalicylate 
3-aminosalicylate 
5-aminosalic ylate 
p-aminobenzoate 
salicylate 
gentisate 
3-nitrosalicylate 
5-nitrosalicylate 
benzoate 
acetylsalicylate 
p-phenylenediamine 
p-aminosulf anilate 
m -aminophenol 
p-quinone 
salicylamide 
phenacetin 
. Titer 
1/64 
1/2 
1/8 
1/64 
1/16 
1/32 
1/2 
1/2 
Reaction 
+-++ 
++ .. 
t 
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(19) described another case where hemolytic anemia was present. 
A similar level of cross-reactivity was observed, but the relative 
reactivities were slightly different from the other case. These 
symptoms are probably caused by antibodies of the IgG and IgM 
classes. 
A few cases have been observed with urticaria! reactions 
(10). These have not been studied in detail and could be caused 
by IgE antibodies. 
In the investigations reported here) various conjugates of 
p-aminosalicylic acid were prepared and injected into rabbits and 
guinea pigs in order to observe the immune reactions elicited. 
Guinea pigs were also sensitized with free p-aminosalicylic acid 
and its sodium salt and their response studied. 
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Results and Discussion 
A. Azo Coupled Antigens 
Aromatic amines were diazotized and coupled to proteins 
by the methods described in Chapter I. Conjugates of para-
azosalicylate, 5-azosalicylate and p-azobenzoate were prepared 
using several carriers, including KLH (keyhole limpet hemocyanin~ 
BGG (bovine gamma globulin), BSA (bovine serum albumin) and 
GPS (normal guinea pig serum). After extensive dialysis the 
conjugates were passed through a column of either Bio-Gel P2 or 
PlO to remove unreacted hapten and side products. After 
chromatography there was no dialyzable color in any of the 
preparations. The absorption spectra of 4-azosalicylate GPS and 
5-azosalieylate GPS are shown in figures 2 and 3. 
A group of small azohaptens were prepared to help in 
characterizing the conjugates and to be used as inhibitors in 
inhibition of precipitation experiments. The azosalicylates were 
coupled directly to phenol (20) and to protected amino acids (21). 
Aniline derivatives were prepared by coupling the azo compound 
to aniline-&J -methylsulfonate, followed by basic hydrolysis (2 O). 
The yields of all the compounds were lower than expected after 
base-acid cycling for purification. The absorption spectra of six 
of these derivatives are shown in figures 4 and 5. The N-acetyl 
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280 
.3 
.2 
. 1 
abs 
300 500 nm 
Figure 2. Absorption spectrum of 4-azosalicylate guinea pig 
serum. Protein concentration 0. 18mg/ ml. 
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Figure 3. Absorption spectrum of 5-azosalicylate guinea pig 
serum. Protein concentration 0. 09mg/ ml. 
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Figure 4. Absorption spectra of azosalicylate derivatives. 
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Figure 5. Absorption spectra of azosalicylate amino acid 
derivatives. 
4-azosalicylate- ortho-N-acetyltyrosine 
----- 4-azosalicylate-N-acetylhistidine 
di-(4-azosalicylate)- E.-aminocaproate 
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tyrosine, N-acetyl histidine and (;-aminocaproate derivatives all 
had similar spectra. The purity of all of these compounds is 
questionable and could not be readily determined. Attempts to 
prepare di-(4-azosalicylate)-N-acetyl tyrosine gave the same 
compound as the preparation of the mono derivative. €-Amino-
caproate forms only a di-(4-azosalicylate) derivative. Both the 
preparation and characterization of the azosalicylate derivatives 
were more difficult than for the corresponding p-azobenzene-
arsonate,,p-azobenzenesulfonate and p-azobenzoate derivatives (22). 
The antigens used for immunization were partially cross-
linked by glutaraldehyde (23). Rabbits and guinea pigs were 
injected intradermally every two weeks with antigen emulsified in 
Freund' s complete adjuvant. They were tested two weeks after 
the third injection. All of the animals immunized with 
azosalicylate conjugates tested negative by both precipitation and 
passive cutaneous anaphylaxis (PCA) tests. The rabbits were 
then injected intravenously with 0. 5 - lmg three times a week for 
three weeks. They were bled and tested seven days after the 
last injection. All of the 4-azosalicylate rabbits were negative; 
however, a group of three rabbits immunized with a p-azobenzoate 
BGG antigen prepared the same way as the 4-azosalicylate 
cmjugates all produced medium to low titers of anti-hapten 
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antibody, when tested against p-azobenzoate KLH by ring test and 
PCA. The results did not change after further immunization. 
Several preparations of 4-azosalicylate antigens were tried in both 
rabbits and guinea pigs, but no antibody was produced. These 
conjugates, however, did elicit delayed skin reactions in guinea 
pigs. These results are discussed in section IV, D. 
Daniel, Perloff, Major and Baum (24) used 4-azosalicylate 
human serum albumin sensitized erythrocytes to study serum from 
human patients in a passive hemagglutination system. 52 out of 
114 samples tested positive. The incidence of positive reactions 
did not show statistically significant differences among normal 
wntrols, p-aminosalicylic acid treated patients, p-aminosalicylic 
acid sensitive patients and patients treated with large amounts of 
aspirin for rheumatoid arthritis. Therapy with p-aminosalicylic 
acid caused a small increase in the serum hemagglutination titer 
of those patients whose sera tested positive the first time. 
These observations give very little information about the 
mechanism of the hypersensitivity and> moreover, could be the 
result of some non-specific or non-pathological reaction. There 
are no reports in the literature of 4-azosalicylate antibody from 
laboratory animals. 
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B. Carbodiimide Coupled Antigens 
Para-aminosalicylate was coupled to proteins and poly-
peptide carriers using 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide, CH3CH2N=C:NCH2CH2CHN(CH3)2, abbreviated as 
ECDI (25). lOOmg of p-aminosalicylic acid was dissolved by 
neutralization with lN NaOH in a total volume of 5ml; lOOmg of 
protein or polypeptide was then dissolved in the solution. lg of 
ECDI in a volume of 2ml was added and the mixture was gently 
stirred for 18 hours. The solution was then dialyzed against 
dilute sodium bicarbonate and four times against saline. Any 
precipitate that formed was redissolved by adjusting the pH with 
NaOH or HCl. 
The reactions involved in carbodiimide coupling and the 
side reactions that occur have been extensively investigated (26). 
The coupling takes place by the reaction of free amino groups 
with either the intermediate compound resulting from the r eaction 
of carbodiimide with free carboxyl groups and/ or the reaction of 
acid anhydrides formed from the intermediate compound. The 
intermediate is an 0-acyl urea whose reactivity is not known; 
however, acids that have symmetrical anhydrides that are 
unreactive toward amines do not form amide bonds with 
carbodiimides and amines (26). The most common r eactions in 
Figure 6. 
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R- N = C=1'- R' + P-COOH 
R-N= C-NHR' 
I 
Q....C- P 
II 
0 
Intermediate compound 
P-COOH 
P - - C-0- C -·P + R1''li-C - 1'H-R' 
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Ac id anhydride Protein-protein conjugate 
Formation of the protein-protein conj ugate 
Rc:i.c tions im·oh·cd in conjui;ation with carbodiimide~K 
from reference 2 7. 
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carbodiimide coupling are diagrammed in figure 6 (27). The 
by-product of the coupling is a disubstituted urea, which can be 
removed by dialysis. The major side reaction is the formation 
of N-acylureas. Although this side reaction is controllable in 
the coupling of small peptides, it is a serious problem in the 
coupling of macromolecules (28). The conjugates prepared in 
this study were highly immunogenic as were those prepared by 
doodfriend~ al. (28). However, precipitation of antigen was not 
inhibited by p-aminosalicylate, and sera prepared against p-
aminosalicylic KLH (coupled by ECDI) cross reacted with ECDI 
treated BGG. Passive cutaneous anaphylaxis experiments with 
rabbit immune sera in guinea pigs gave similar results. 
A second problem of ECDI coupled conjugates is the 
presence of reactive groups, which can cross-link the antigen to 
other serum proteins,, forming a non-specific precipitate. This 
was discovered by observing that precipitation reactions still 
' 
occurred after immune serum was absorbed three successive 
times with huge excesses of antigen trapped in a polyacrylamide 
gel matrix (29). The antigen also gave a precipitate with normal 
serum. These reactive groups were not blocked by treatment 
of the antigen with a large excess of free p-aminosalicylate, or 
large excesses of glycine or lysine. Coupling was also tried 
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over a pH range of 5 to 8, but the same problems persisted in 
each preparation. 
P-aminosalicylate was coupled to BGG by ECDI. Spectral 
evidence obtained from a thoroughly dialyzed sample showed a 
significant amount of coupling, approximately 20 hapten residues 
coupled to each BGG molecule. The spectrum of p-aminosalicylate 
in base is shown in figure 7 and those of p-aminosalicylic BGG 
and ECDI treated BGG are shown in figure 8. The concentrations 
of BGG in both samples in figure 8 differ by less than 5%. The 
changes are quite obvious. 
Two experiments were done to determine the direction of 
coupling of p-aminosalicylate. In the first experiment p-amino-
salicylate was coupled to polyglutamic acid. The spectrum of 
the dialyzed product is shown in figure 9 and it shows that 
coupling did take place to form polyglutamylaminosalicylate. The 
results of the second experiment are shown in figure 10; 
p-aminosalicylate also coupled to polylysine to form p-amino-
salicylylpolylysine. This product was used to demonstrate that 
the p-aminosalicylate is covalently bound. A thoroughly dialyzed 
sample was diluted 10 times with water, and then pressure 
diafiltered through an Amicon UM20e (cutoff 20, 000 molecular 
weight) membrane. This was repeated three times for a total 
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Figure 7. Absorption spectrum of para-aminosalicylate in base. 
Extinction coefficients 14, 000, 9000. 
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Figure 8. Absorption spectra of carbodiimide coupled antigens. 
--- p-aminosalicylic BGG, ECDI coupled, approximately 20 moles 
of hapten coupled per mole of BGG. 
----- BGG treated with ECDI, about the same concentration of 
protein. 
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Figure 9. Absorption spectrum of polyglutamylsalicylate amide. 
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Figure 10. Absorption spectra of p-aminosalicylylpolylysine. 
Dialyzed 
----- Dialyzed and then diafiltered 3 times for a total dilution of 
1 to 1000. Final dilution is 1. 3 times that of the original 
sample. 
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dilution of 1 to 1000. After correction for volume change, the 
spectra agreed within 2%, which is less than the experimental 
error. The polyglutamate conjugates caused only a faint non-
specific precipitation, while the polylysine conjugates caused a 
strong non-specific precipitation. 
There are several other side reactions of carbodiimides 
which may be important in the systems investigated. Aromatic 
amines can react with with carbodiimides under mild conditions 
to form trisubstituted guanidines (30) as is shown in figure 11. 
Only strongly acidic phenols such as picric acid react 
with carbodiimides, and this reaction only occurs at elevated 
temperatures (31). Non-aromatic hydroxy groups are not 
reactive with carbodiimide under mild conditions (32). Formation 
of cyclic compounds such as (}-lactones from amino acids by 
carbodiimide treatment is not unusual (33). Figure 12 shows 
the reaction of protected histidine. Similar reactions may take 
place with the free functional groups on macromolecules. 
o~keO+Ark=C=kAr 4 ArN=CNHAr I 
NHR 
Figure 11. Reaction of carbodiimide with aromatic amines. 
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+ RN=C=NR 
Figure 12. The reaction of carbobenzoxyhistidine with 
ca.rbodiimide. 
The reaction of carbodiimide with gelatin has been studied 
to some extent (34). Sheehan and Hlavka performed the reaction 
of gelatin with carbodiimide in aqueous solution and measured the 
cross-linking by the decrease in gelling time and eventual 
liquefaction. After extensive treatment with an equal weight of 
water soluble carbodiimide only 10% of the free amino and 
carboxyl groups remained. Benzoylated gelatin did not gel or 
cross-link with carbodiimide, showing the necessity of free amino 
groups for intermolecular coupling. 
P-aminosalicylate may also react with carbodiimide without 
coupling. The phenol is not particularly acidic so it does not 
participate directly (31) . Zetzsche and Voigt (35) have found that 
ortho, meta and para-aminobenzoic acids react with carbodiimides 
to form a urea at the amine and an amide at the carboxyl. 
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RN=C=NR 
OCONHR 
CONHR 
Figure 13. Reaction of p-aminobenzoic acid with diaryl 
carbodiimides. 
P-aminobenzoic acid reacts with diaryl carbodiimides under mild 
conditions to give the product shown in figure 13. The final 
product is not reactive with either amino or carboxyl groups. 
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C. Mixed Anhydride Coupling by Ethyl Chloroformate 
Ethyl chlorof ormate (EtChf) has been used for crosslinking 
proteins to prepare immunoadsorbents and insoluble enzymes (36). 
The two primary reactions that take place are mixed anhydride 
coupling to form peptide bonds and the formation of ureas by the 
coupling of two amino groups. The presence of ureas was established 
by the carbamido diacetyl test (36). Insolubilization takes place 
most rapidly around the isoelectric point,and with many proteins 
does not occur when the reaction is carried out at a pH 2 or 3 units 
away from the isoelectric point. 
In the first experiment p-aminosalicylate was coupled to 
normal guinea pig serum by ethyl chloroform ate without buffer. The 
pH was in the range of 5 to 7. After extensive dialysis and 
diafiltration, the absorption spectrum measured in acid showed 
coupling had occurred. The spectrum lost the peaks characteristic 
of p-aminosalicylate (see figure 7) , when it was measured in base. 
The spectra are reproduced in figure 14. 
When this experiment was repeated, no coupling took place. 
A series of reactions were set up using several amino haptens and 
proteins at various pH's. Some of them are tabulated in table 2. No 
coupling was observed in any case. Where precipitation occurred, 
the supernatant was examined, and if the hapten was colored, the 
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Figure 14. Absorption spectra of p-aminosalicylic guinea pig 
serum coupled by ethyl chloroformate. 
in acid 
in base 
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Table 2. Ethyl Chloroformate Coupling Experiments 
Hap ten Protein pH Coupling 
p -aminosalic ylate guinea pig serum 5-7 t 
p-aminosalicylate guinea pig serum 6 
aniline BGG 4.5 
p-aminosalicylate ovalbumin 6 
p-aminosalicylate RSA 8.6 
p-aminosalicylate BGG 3.9 
aniline BGG 3.8 
2, 4-dinitroaniline BGG 3.8 
p-ni troaniline guinea pig serum 8 
p-ni trobenzoate guinea pig serum 8 
precipitate was thoroughly washed and visually examined. The amim 
and carboxyl groups of the protein appear to react more rapidly with 
the ethyl chloroformate than with the haptens. Outside the range of 
2 pH units around the isoelectric point the functional groups of the 
protein are unreactive. 
The coupled p-aminosalicylic guinea pig serum from the first 
experiment was injected in Freund' s adjuvant into guinea pigs and 
rabbits. None of the sera obtained from these animals gave positive 
reactions in PCA against ECDI coupled p - aminosalicylic KLH. 
142 
D. Delayed Skin Reactions to para-Aminosalicylic Acid Conjugates 
in Guinea Pigs 
Normal guinea pigs were immunized with five O. lml 
intradermal injections of antigen emulsified in Freund's complete 
adjuvant on day 0. Each animal received a total of 7 micrograms 
of antigen. Each animal was tested by intradermal injection of 
0. lml of each test antigen on day 10 and the reaction was 
measured after 4, 24 and 48 hours. A tuberculin test was 
performed on each animal to provide a positive control. The 
Mycobacteria in the adjuvant cause tuberculin reactivity to develop 
in the animals. The polylysine conjugate was an irritant and 
caused a reaction of about 9mm diameter to develop in both 
sensitized and control animals. The other conjugates were 
relatively non-irritating. The results of the tests are tabulated 
in table 3. The orders of reactivities are consistent with other 
systems that have been studied (37, 38, 39, 40). 
The animals that had been sensitized with 4-azosalicylate 
guinea pig serum (GPS) reacted most strongly with the sensitizing 
antigen. The reaction with PABGPS was very weak; only one 
out of three animals tested positive. 4-azosalicylate KLH gave a 
strong reaction, probably due to the high hapten coupling ratio of 
the preparation; there was about 5 to 7 times the amount of 
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Table 3. Delayed Reactions to Conjugates in Guinea Pigs 
Sensitized with 
Test Antigen mg/ ml Control PABGPS* 4-SalGPS 5-Sal PASGPS 
GPS (EtChf) 
4-SalGPS .35 -** 10 11 10 9 
4-SalGPS . 07 8 
4-SalKLH . 30 10 
4-SalBSA . 67 2 
5-SalGPS . 36 9 5 13 
5-SalGPS . 07 10 
PABGPS . 36 17 2 9 
PABGPS . 07 11 
PABGPS . 004 10 
PABBSA . 09 10 
PASGPS(EtChf) . 42 2 18 
PASGPS(EtChf) . 08 9 
PASpLys(ECDI) . 44 9 10 
PASpGlu(ECDI) .15 10 
PASGPS(ECDI) . 43 17 
PPD . 05TU 10 10 9 11 
normalGPS . 12 
continued 
Table 3. continued 
PAS 1. 0 
PCA, 4-SalKLH 
PCA, 4-SalGPS 
Saline 
Notes 
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* PAB is p-azobenzoate, 4-Sal is p-azosalicylate, PAS is p-amino-
salicylic acid or salicylate, PPD is purified protein derivative 
from tuberculin, TU are tuberculin units, the methods of antigen 
preparation are in parentheses. 
** - is no reaction, numbers in the last five columns are the average 
diameters of the reactions from at least three animals, the units are 
mm. Blanks were not done. 
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hapten coupled per mg protein more than the other conjugates 
used. 4-azosalicylate BSA gave a very weak reaction. 5-azo-
salicylate GPS gave a reaction half the size of the homologoos 
reaction; p-aminosalicylate GPS (ethyl chloroformate coupled) 
gave a negative reaction. 
Guinea pigs immunized with 5-azosalicylate GPS reacted 
very strongly with the sensitizing antigen and somewhat more 
weakly with 4-azosalicylate GPS and p-azobenzoate GPS. The 
reaction with p-aminosalicylic GPS was very weak. 
Para-aminosalicylic GPS coupled by ethyl chlorof ormate 
was as potent an antigen as p-azobenzoate GPS. The carbodiimide 
coupled preparation reacted almost as strongly as the immunizing 
preparation. 4-azosalicylate GPS and the p-aminosalicylic acid 
polyglutamic acid conjugate each gave reactions about half the 
diameter of those caused by the immunizing conjugate. 
Experiments were done with p-azobenzoate GPS for 
comparison. The immunizing conjugates reacted quite strongly 
and 4-azosalicylate GPS, 5-azosalicylate GPS and p-azobenzoate 
BSA all caused reactions about half the diameter of those caused 
by p-azobenzoate GPS. 
The 4-azosalicylate GPS guinea pigs were bled and their 
sera were tested against 4-azosalicylate KLH and 4-azosalicylate 
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GPS by PCA in normal guinea pigs, after an 18 hour sensitizing 
period. These tests were all negativeJ showing the absence of 
skin sensitizing antibodies. Precipitation tests were also negative. 
The experiments described above indicate a significant degree 
of hapten specificity in the salicylate systems studied in delayed 
hypersensitivity. 4-azosalicylate cross reacts less with 5-azo-
salicylate than the reverse. P-azobenzoate does not react 
significantly with 4-azosalicylate sensitized animals, but cross 
reacts strongly with the 5-azosalicylate sensitized animals. The 
two p-aminosalicylic acid preparations each gave similar size 
reactions in the same animals. This indicates that they probably 
share many determinants; however these animals did exhibit a 
broad range of cross-reactivity. The variable amounts of 
carrier specificity were expected. The reactivity of the poly-
glutamic acid conjugate showed that some of the coupling was 
through the amino group of the p-aminosalicylate. 
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E. Contact Sensitivity to p-Aminosalicylate in Guinea Pigs 
Guinea pigs were injected with p-aminosalicylate in Freund's 
complete adjuvant emulsions using the amJunts and procedures 
described for aspirin in chapter m. The animals were tested by 
topical application of p-aminosalicylic acid in propylene glycol and 
methyl ethyl ketone,and by both application and injection of p-amino-
salicylate in water. Concentrations of up to 2mg/ ml were non-
irritating. All of these tests were negative as were the tests with 
free hapten on the animals sensitized with conjugates. 
A method was tried with one group of guinea pigs that had 
given excellent results with p-phenylenediamine (12). 1 gram of p-
aminosalicylic acid was mixed with 9g of Vaseline brand petroleum 
jelly. The mixture was topically applied to a shaved area on the 
flank of the guinea pigs daily for 7 consecutive days. On day 21 the 
guinea pigs were tested with 10% p-aminosalicylic acid, p-phenyl-
enediamine, 5-aminosalicylic acid and p-aminobenzoic acid in 
Vaseline. All of the reactions were either negative or weak enough 
to be masked by the color of the test substance. At day 14 the area 
where the sensitizer was applied seemed thickened. If any sensitivity 
was produced, it was very weak. These animals did not react to 
p-aminosalicylic acid conjugates. 
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F. The Farr Technique for Determining Binding Constants 
Stupp, Yoshida and Paul (41) found that a modification of the 
Farr technique could be used for determining the binding of dinitro-
phenyl-€-aminocaproate to antibody. The method consists of 
incubating dilutions of hapten with immune serum, immune serum 
globulins, or purified antibody> then adding 2 volumes of 75% saturated 
ammonium sulfate and centrifuging. Aliquots of the supernatant were 
counted to determine free hapten concentrations. 
This technique was tested with the model system, p-azo-
benzoate. Anti-p-azobenzoate BGG serum was incubated with dilutions 
of p-aminobenzoate-14c (specific activity 13. 5 mc/ mM). The 
experiment was repeated several times and each time the log-log 
plot had a slope of 1. Binding constants were from 105 to 1. 6xl05; 
this is about an order of magnitude higher than expected from 
previous results. 
Six series of tubes were set up and buffer was added to one set. 
Five substituted benzoates were added at three concentrations each to 
the other five series of tubes. The measured binding was the same 
within experimental error for each series including the buffer control. 
This showed that inhibition did not occur. The results were nothing 
like calculations predicted for competitive binding (42). The binding 
observed was probably a result of non-specific absorption of the 
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hapten to precipitated protein and precipitation of hapten caused by 
the decrease in pH when the ammonium sulfate was added. This 
method does not appear to be applicable to substituted benzoic acids 
and may only work for special cases like dinitrophenyl haptens. 
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Materials and Methods 
Most of the materials and methods used in this investigation are 
described in the previous chapters. 
Reagents 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide HCl was lot 
number SN1895 from Ott Chemical Company, Muskegon, Michigan. 
Poly-I- lysine had an average molecular weight of 62, 000 as 
the hydrobromide,and poly-1-glutamic acid had an average molecular 
weight of 59, 000. Both of these polypeptides were products of Yeda, 
Ltd. , Rehovoth, Israel. 
Both 4-aminosalicylic acid and 5-aminosalicylic acid were 
purchased from Aldrich Chemical Company, Inc., Milwaukee, 
Wisconsin. There were no significant impurities in the 4-amino-
salicylic acid. Both crystals and solutions of the 5-aminosalicylic 
acid were colored; this color was not removable by either 
recrystallization or acid precipitation. 
Methods 
Aniline-lJ-methylsulfonate (43). 
1. 1 e quivale nts (1. 14g) of sodium bisulfite in a s a tura te d 
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solution was added to 1 equivalent (8ml) of formalin. After standing 
30 minutes, 1 equivalent (9. 3g) of aniline was added and the mixture 
was heated to 75 - 80° with stirring until it became clear. It was 
then cooled and a mass of crystals formed. The crystals were 
filtered off, washed in ice water and ether and finally vacuum dried. 
Glutaraldehyde Crosslinking (23) 
8ml of lM dibasic potassium phosphate was added to 50ml of 
p-azobenzoate BGG containing 350mg,and the pH was adjusted to 6. 4 
with lM acetic acid. 2ml of 2. 5% glutaraldehyde was dropped in over 
10 minutes. The pH was reduced to 5. 9 and then to 5. 5 until slight 
cloudiness appeared. 7ml of lM lysine HCl was then added. After 
stirring for 15 minutes, the crosslinked antigen was extensively 
dialyzed. 
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Conclusions 
Protein conjugates were prepared with p-aminosalicylic acid 
and various carriers using azo coupling, carbodiimide coupling and 
mixed anhydride coupling by ethyl chloroformate. These antigens 
were injected into rabbits and guinea pigs and no anti-hapten IgG 
or IgM response was obtained. Delayed hypersensitivity was 
produced in guinea pigs by immunization with the conjugates, and 
its specificity was determined. Guinea pigs were not sensitized 
by injections or topical applications of p-aminosalicylic acid or 
p-aminosalicylate. 
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